<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK541728" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK541728/" /><meta name="ncbi_pagename" content="Apert Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Apert Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Apert Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/05/30" /><meta name="citation_author" content="Tara L Wenger" /><meta name="citation_author" content="Anne V Hing" /><meta name="citation_author" content="Kelly N Evans" /><meta name="citation_pmid" content="31145570" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK541728/" /><meta name="citation_keywords" content="Acrocephalosyndactyly Type I" /><meta name="citation_keywords" content="Fibroblast growth factor receptor 2" /><meta name="citation_keywords" content="FGFR2" /><meta name="citation_keywords" content="Apert Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Apert Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Tara L Wenger" /><meta name="DC.Contributor" content="Anne V Hing" /><meta name="DC.Contributor" content="Kelly N Evans" /><meta name="DC.Date" content="2019/05/30" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK541728/" /><meta name="description" content="Apert syndrome is characterized by the presence of multisuture craniosynostosis, midface retrusion, and syndactyly of the hands with fusion of the second through fourth nails. Almost all affected individuals have coronal craniosynostosis, and a majority also have involvement of the sagittal and lambdoid sutures. The midface in Apert syndrome is underdeveloped as well as retruded; a subset of affected individuals have cleft palate. The hand in Apert syndrome always includes fusion of the middle three digits; the thumb and fifth finger are sometimes also involved. Feeding issues, dental abnormalities, hearing loss, hyperhidrosis, and progressive synostosis of multiple bones (skull, hands, feet, carpus, tarsus, and cervical vertebrae) are also common. Multilevel airway obstruction may be present and can be due to narrowing of the nasal passages, tongue-based airway obstruction, and/or tracheal anomalies. Nonprogressive ventriculomegaly is present in a majority of individuals, with a small subset having true hydrocephalus. Most individuals with Apert syndrome have normal intelligence or mild intellectual disability; moderate to severe intellectual disability has been reported in some individuals. A minority of affected individuals have structural cardiac abnormalities, true gastrointestinal malformations, and anomalies of the genitourinary tract." /><meta name="og:title" content="Apert Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Apert syndrome is characterized by the presence of multisuture craniosynostosis, midface retrusion, and syndactyly of the hands with fusion of the second through fourth nails. Almost all affected individuals have coronal craniosynostosis, and a majority also have involvement of the sagittal and lambdoid sutures. The midface in Apert syndrome is underdeveloped as well as retruded; a subset of affected individuals have cleft palate. The hand in Apert syndrome always includes fusion of the middle three digits; the thumb and fifth finger are sometimes also involved. Feeding issues, dental abnormalities, hearing loss, hyperhidrosis, and progressive synostosis of multiple bones (skull, hands, feet, carpus, tarsus, and cervical vertebrae) are also common. Multilevel airway obstruction may be present and can be due to narrowing of the nasal passages, tongue-based airway obstruction, and/or tracheal anomalies. Nonprogressive ventriculomegaly is present in a majority of individuals, with a small subset having true hydrocephalus. Most individuals with Apert syndrome have normal intelligence or mild intellectual disability; moderate to severe intellectual disability has been reported in some individuals. A minority of affected individuals have structural cardiac abnormalities, true gastrointestinal malformations, and anomalies of the genitourinary tract." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK541728/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/apert/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK541728/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE881A0BE0416F510000000008E50364.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK541728_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK541728_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/angelman/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/arg1/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK541728_"><span class="title" itemprop="name">Apert Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Acrocephalosyndactyly Type I</div><p class="contrib-group"><span itemprop="author">Tara L Wenger</span>, MD, PhD, <span itemprop="author">Anne V Hing</span>, MD, and <span itemprop="author">Kelly N Evans</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK541728_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK541728_ai__"><div class="contrib half_rhythm"><span itemprop="author">Tara L Wenger</span>, MD, PhD<div class="affiliation small">Seattle Children's Hospital<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.snerdlihcelttaes@regnew.arat" class="oemail">gro.snerdlihcelttaes@regnew.arat</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Anne V Hing</span>, MD<div class="affiliation small">Seattle Children's Hospital<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.snerdlihcelttaes@gnih.enna" class="oemail">gro.snerdlihcelttaes@gnih.enna</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Kelly N Evans</span>, MD<div class="affiliation small">Seattle Children's Hospital<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.snerdlihcelttaes@snave.yllek" class="oemail">gro.snerdlihcelttaes@snave.yllek</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 30, 2019</span>.</p><p><em>Estimated reading time: 32 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="apert.Summary" itemprop="description"><h2 id="_apert_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Apert syndrome is characterized by the presence of multisuture craniosynostosis, midface retrusion, and syndactyly of the hands with fusion of the second through fourth nails. Almost all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have coronal craniosynostosis, and a majority also have involvement of the sagittal and lambdoid sutures. The midface in Apert syndrome is underdeveloped as well as retruded; a subset of affected individuals have cleft palate. The hand in Apert syndrome always includes fusion of the middle three digits; the thumb and fifth finger are sometimes also involved. Feeding issues, dental abnormalities, hearing loss, hyperhidrosis, and progressive synostosis of multiple bones (skull, hands, feet, carpus, tarsus, and cervical vertebrae) are also common. Multilevel airway obstruction may be present and can be due to narrowing of the nasal passages, tongue-based airway obstruction, and/or tracheal anomalies. Nonprogressive ventriculomegaly is present in a majority of individuals, with a small subset having true hydrocephalus. Most individuals with Apert syndrome have normal intelligence or mild intellectual disability; moderate to severe intellectual disability has been reported in some individuals. A minority of affected individuals have structural cardiac abnormalities, true gastrointestinal malformations, and anomalies of the genitourinary tract.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of Apert syndrome is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with classic clinical characteristics (multisuture craniosynostosis, midface retrusion, and syndactyly) and/or by the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FGFR2</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> AND phenotypic features consistent with Apert syndrome.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Management by a craniofacial team is ideal. In general, multisutural craniosynostosis should be surgically repaired in the first year of life; jaw surgery to advance the midface often occurs in childhood and adolescence. Cleft palate repair may be performed prior to the development of pressure consonants. Feeding therapy is often helpful. Pediatric dental care is recommended. Treatment of strabismus should be performed by an ophthalmologist with expertise in eye alignment in children with craniosynostosis. Hearing aids may be required for hearing loss. If airway obstruction is present, temporizing measures may be required. Treatment of sleep apnea by surgical intervention and/or supplemental oxygen via nasal cannula may be required. The type and timing of surgical repair for syndactyly depends on the presence of thumb syndactyly and extent of soft tissue deficiency. Early intervention services for speech abnormalities and developmental delay should be initiated. Standard treatment of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects, malrotation, cryptorchidism in males, hydronephrosis, acne, and scoliosis should be instituted when appropriate.</p><p><i>Prevention of secondary complications:</i> Timely surgical treatment of craniosynostosis may prevent increased intracranial pressure that can lead to papilledema and cognitive impairment; ocular lubricants to prevent exposure keratopathy and corneal scarring; anesthesia evaluation before any surgical intervention to prevent perioperative respiratory complications; spine precautions and consultation with a spine surgeon to prevent spinal cord injury and neurologic sequelae in those with cervical spine anomalies. Clinical feeding evaluation and/or video fluoroscopic swallow study is needed to determine if precautions are required to prevent aspiration pneumonia and subsequent chronic lung disease.</p><p><i>Surveillance:</i> Measurement of head circumference and fontanelle size and assessment for increased intracranial pressure at each appointment in infancy and early childhood; assessment of developmental progress at each visit; evaluation by a craniofacial team regularly in infancy, childhood, and adolescence; dental care every six months; assessment for velopharyngeal insufficiency after emergence of language; assessment for speech disorders, ophthalmologic evaluation, and audiologic/otologic assessments at least annually; evaluation for the development of scoliosis annually in childhood and adolescence.</p><p><i>Agents/circumstances to avoid:</i> Contact sports and activities that involve neck hyperflexion or extension for those with cervical spine anomalies; factors that potentiate hearing loss; use of CPAP/BiPAP for long-term treatment of sleep apnea.</p><p><i>Pregnancy management:</i> For <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> pregnant women: monitoring for signs and symptoms of worsening obstructive sleep apnea and anethesia evaluation prior to initiation of labor to identify any multilevel airway anomalies or vertebral anomalies that would result in additional risk with certain types of anesthesia; fiberoptic intubation could be required.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Apert syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. However, most individuals with Apert syndrome have the disorder as the result of a <i>de novo FGFR2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Advanced paternal age has been shown to be associated with <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants for Apert syndrome. Affected individuals have a 50% chance of passing the pathogenic variant to each child. Prenatal testing for pregnancies at increased risk is possible if the pathogenic variant has been identified in the family.</p></div></div><div id="apert.Diagnosis"><h2 id="_apert_Diagnosis_">Diagnosis</h2><p>Consensus clinical diagnostic criteria for Apert syndrome have not been published.</p><div id="apert.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Apert syndrome <b>should be suspected</b> in individuals with the following clinical features.</p><p><b>Head</b></p><ul><li class="half_rhythm"><div>Multisuture craniosynostosis, most commonly involving bilateral coronal sutures with variable involvement of the remaining cranial sutures</div></li><li class="half_rhythm"><div>Midface retrusion with a greater degree of vertical impaction than Crouzon syndrome (see <a href="/books/n/gene/craniosynostosis/"><i>FGFR</i>-Related Craniosynostosis Syndromes</a>)</div></li><li class="half_rhythm"><div>Prominent eyes with downslanting palpebral fissures</div></li><li class="half_rhythm"><div>Relative prognathism with malocclusion</div></li></ul><p><b>Airway.</b> Multilevel airway obstruction</p><p><b>Limbs/skeleton</b></p><ul><li class="half_rhythm"><div>Syndactyly of the hands, including soft tissue and bone</div><ul><li class="half_rhythm"><div>The second, third, and fourth fingers are always included in the fusion, while the thumb and fifth digit may or may not be included.</div></li><li class="half_rhythm"><div>Synonychia (fusion of &#x02265;2 nails) of the second through fourth fingers is common. The appearance is sometimes referred to as a "mitten hand."</div></li></ul></li><li class="half_rhythm"><div>Syndactyly of the feet, which may or may not include the great toe</div></li><li class="half_rhythm"><div>Tendency toward progressive bony fusion at multiple sites (e.g., progressive craniosynostosis, cervical vertebral fusions, bones of the hands and feet, carpus, and tarsus). Bony fusions (especially of the skull) may also occur after birth.</div></li></ul></div><div id="apert.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of Apert syndrome <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with:</p><ul><li class="half_rhythm"><div>Classic clinical characteristics (multisuture craniosynostosis, midface retrusion, and syndactyly); OR</div></li><li class="half_rhythm"><div>Suggestive clinical features AND a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FGFR2</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK541728/table/apert.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figapertTmoleculargenetictestingusedi" rid-ob="figobapertTmoleculargenetictestingusedi">Table 1</a>).</div></li></ul><p>When the phenotypic findings suggest the diagnosis of Apert syndrome, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>.</p><p>Note: All individuals with Apert syndrome have a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FGFR2</i>, though clinicians may choose a targeted panel including common pathogenic variants that cause other forms of <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> craniosynostosis if the diagnosis is unclear or if this approach is the most cost effective.</p><p><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>FGFR2</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants. Typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected.</p><ul><li class="half_rhythm"><div>Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first.</div></li><li class="half_rhythm"><div>If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div></li></ul><p><b>A craniosynostosis</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>FGFR2</i> and other genes of interest (see <a href="#apert.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><div id="apert.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Apert Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541728/table/apert.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__apert.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_apert.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_apert.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_apert.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_apert.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR2</i></td><td headers="hd_h_apert.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_apert.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~99%&#x000a0;<sup>4,&#x000a0;5</sup></td></tr><tr><td headers="hd_h_apert.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_apert.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="apert.TF.1.1"><p class="no_margin">See <a href="/books/NBK541728/#apert.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="apert.TF.1.2"><p class="no_margin">See <a href="#apert.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="apert.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="apert.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#apert.REF.park.1995.321">Park et al [1995]</a>, <a class="bk_pop" href="#apert.REF.wilkie.1995.165">Wilkie et al [1995]</a>, <a class="bk_pop" href="#apert.REF.moloney.1996.48">Moloney et al [1996]</a>, <a class="bk_pop" href="#apert.REF.oldridge.1997.137">Oldridge et al [1997]</a>, <a class="bk_pop" href="#apert.REF.lajeunie.1999.443">Lajeunie et al [1999]</a></p></div></dd><dt>5. </dt><dd><div id="apert.TF.1.5"><p class="no_margin">Several pathogenic variants are recurrent and commonly seen: <a class="figpopup" href="/books/NBK541728/table/apert.T.fgfr2_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figapertTfgfr2pathogenicvariantsdiscus" rid-ob="figobapertTfgfr2pathogenicvariantsdiscus">p.Ser252Trp</a> (62%-71%), <a class="figpopup" href="/books/NBK541728/table/apert.T.fgfr2_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figapertTfgfr2pathogenicvariantsdiscus" rid-ob="figobapertTfgfr2pathogenicvariantsdiscus">p.Pro253Arg</a> (26%-33%), and <a class="figpopup" href="/books/NBK541728/table/apert.T.fgfr2_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figapertTfgfr2pathogenicvariantsdiscus" rid-ob="figobapertTfgfr2pathogenicvariantsdiscus">p.Ser252Phe</a> (&#x0003c;1%-3%).</p></div></dd><dt>6. </dt><dd><div id="apert.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="apert.TF.1.7"><p class="no_margin"><a class="bk_pop" href="#apert.REF.oldridge.1999.446">Oldridge et al [1999]</a>, <a class="bk_pop" href="#apert.REF.bochukova.2009.204">Bochukova et al [2009]</a>, <a class="bk_pop" href="#apert.REF.fenwick.2011.122">Fenwick et al [2011]</a></p></div></dd></dl></div></div></div></div></div><div id="apert.Clinical_Characteristics"><h2 id="_apert_Clinical_Characteristics_">Clinical Characteristics</h2><div id="apert.Clinical_Description"><h3>Clinical Description</h3><p>Apert syndrome shows substantial overlap with the clinical characteristics seen in other <i>FGFR2</i>-associated craniosynostosis syndromes (e.g., craniosynostosis, midface retrusion, vertebral fusions). In most individuals, Apert syndrome can be readily distinguished from other <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> craniosynostosis syndromes (e.g., Crouzon, Pfeiffer, Jackson-Weiss, Beare-Stevenson) at or before birth due to the presence of syndactyly. However, several other important distinguishing features have implications for surveillance and medical management (see <a href="#apert.Management">Management</a>).</p><p><b>Craniosynostosis</b> is a near-universal finding in individuals with Apert syndrome, though some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with other typical manifestations (e.g., midface retrusion and syndactyly) without craniosynostosis have been reported. Most infants with Apert syndrome are born with fusion of one or more cranial sutures, though progressive craniosynostosis of other sutures can occur. As bony fusions are typically progressive in Apert syndrome, and most major cranial sutures do not typically fuse until adulthood, it is unknown whether the children reported with Apert syndrome without craniosynostosis at the time of diagnosis would go on to develop craniosynostosis later.</p><p>Depending on the involved sutures, most children with Apert syndrome have a large anterior fontanelle, which is displaced anteriorly onto the forehead [<a class="bk_pop" href="#apert.REF.cohen.1996.45">Cohen &#x00026; Kreiborg 1996</a>]. The most commonly involved sutures are the following:</p><ul><li class="half_rhythm"><div>Coronal (near 100%), though many will have multisuture craniosynostosis or pan synostosis resulting in cloverleaf skull</div></li><li class="half_rhythm"><div>Sagittal (~85%)</div></li><li class="half_rhythm"><div>Lambdoid (81%)</div></li></ul><p><b>Midface retrusion.</b> Unlike Crouzon syndrome, in which the midface is normally formed but retruded, the midface in Apert syndrome is underdeveloped as well as retruded. There is a greater degree of vertical impaction leading to a shorter maxillary bone, with greater similarity to Pfeiffer syndrome than to Crouzon syndrome. The underdevelopment of the midface contributes to the development of shallow orbits and downslanting palpebral fissures. Underdeveloped maxillary structures result in malocclusion and the appearance of relative mandibular prognathism [<a class="bk_pop" href="#apert.REF.cohen.1996.45">Cohen &#x00026; Kreiborg 1996</a>].</p><p><b>Palatal abnormalities.</b> Highly arched palate or cleft palate may occur. Cleft palate is frequently present in Apert syndrome (but rarely found in Crouzon syndrome) [<a class="bk_pop" href="#apert.REF.cohen.1996.45">Cohen &#x00026; Kreiborg 1996</a>].</p><p><b>Feeding issues.</b> Feeding problems are common in children with Apert syndrome and have a number of causes. Palatal anomalies can cause difficulty with generating suction and therefore difficulty with intake of sufficient volume.</p><p>Narrowing of the choanae or nasal turbinates can cause respiratory distress, which can be mistaken for a primary feeding issue. In this case, the infant will often suck a few times and then unlatch to breathe through an open mouth. Infants who have a primary respiratory cause for their feeding issues generally have difficulty breathing through the nose and have other signs of upper-respiratory obstruction.</p><p>Children with Apert syndrome are at risk for gastrointestinal issues (see below) that can cause vomiting but do not typically affect the transfer of milk from the bottle or breast. Many children with Apert syndrome who have feeding difficulties require surgical intervention (e.g., repair of choanal atresia or stenosis, gastrostomy tube).</p><p>Clinical feeding evaluation and/or video fluoroscopic swallow study should be performed for all infants to identify aspiration (see <a href="#apert.Management">Management</a>). If there is aspiration, precautions should be taken (e.g., thickened feeds, limiting oral intake) to prevent aspiration pneumonia, pneumonitis, and chronic lung disease.</p><p><b>Dental abnormalities.</b> Children with Apert syndrome often have dental anomalies that require management by orthodontics and/or oromaxillofacial surgery. Tooth agenesis (typically of maxillary canines) and enamel opacities occur in more than 40% of children with Apert syndrome. Ectopic eruption of maxillary first molars and lateral palatal swellings are also common. Other orthodontic differences include delayed dental eruption, missing teeth, dental crowding, and abnormal occlusal relationships. Abnormalities of primary and adult teeth can be present [<a class="bk_pop" href="#apert.REF.nurko.2004.541">Nurko &#x00026; Quinones 2004</a>, <a class="bk_pop" href="#apert.REF.dalben.2006.465">Dalben et al 2006</a>].</p><p><b>Ocular abnormalities.</b> The characteristic appearance of the eyes in Apert syndrome is prominent with downslanting palpebral fissures. The prominence of the eyes is typically due to a combination of bicoronal craniosynostosis and deficient development of the maxilla. Other primary ophthalmologic abnormalities include the following:</p><ul><li class="half_rhythm"><div>Strabismus (60%)</div></li><li class="half_rhythm"><div>Refractive error (34%)</div></li><li class="half_rhythm"><div>Anisometropia (19%)</div></li></ul><p>Secondary ophthalmologic findings that may develop over time include exposure keratopathy and corneal scarring (8%) and optic atrophy (8%). These secondary findings may be preventable with aggressive surveillance and treatment of incomplete lid closure and increased intracranial pressure [<a class="bk_pop" href="#apert.REF.khong.2006b.347">Khong et al 2006b</a>].</p><p><b>Hearing loss/inner ear anomalies.</b> Hearing loss is common (80%) and is typically conductive, caused by middle ear disease, ossicular abnormalities, and external auditory canal stenosis or atresia [<a class="bk_pop" href="#apert.REF.agochukwu.2014.2037">Agochukwu et al 2014</a>].</p><p>Abnormalities of the semicircular canals are found in 70% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p><p><b>Multilevel airway obstruction.</b> Individuals with Apert syndrome may have abnormalities at multiple sites [<a class="bk_pop" href="#apert.REF.cohen.1992.90">Cohen &#x00026; Kreiborg 1992</a>, <a class="bk_pop" href="#apert.REF.cohen.1996.45">Cohen &#x00026; Kreiborg 1996</a>, <a class="bk_pop" href="#apert.REF.wenger.2017.62">Wenger et al 2017</a>].</p><ul><li class="half_rhythm"><div class="half_rhythm">Narrowing of the nasal passages or choanae can lead to upper-airway obstruction, and may contribute to respiratory distress as well as feeding difficulties.</div></li><li class="half_rhythm"><div class="half_rhythm">Tongue-based airway obstruction may also occur.</div><div class="half_rhythm">In children with cleft palate, repair of the cleft palate may unmask obstruction at the level of the pharynx and result in worsening of obstructive sleep apnea.</div></li><li class="half_rhythm"><div class="half_rhythm">Tracheal anomalies, including fused rings and tracheal cartilaginous sleeves, have been reported in a number of individuals.</div><ul><li class="half_rhythm"><div>Significant variability in severity is seen, ranging from mild respiratory symptoms requiring little intervention to severe obstruction requiring placement of tracheostomy.</div></li><li class="half_rhythm"><div>Some children who require tracheostomy need a ventilator for delivery of positive airway pressure during sleep.</div></li></ul></li></ul><p><b>Syndactyly.</b> The hand in Apert syndrome always includes fusion of the middle three digits; the thumb and fifth finger may also be involved. The fingernail for digits 2-4 is typically fused to form a single nail (synonychia). Syndactyly of the toes may involve the lateral three digits, digits 2-5, or all digits. In general, the upper limb is more severely affected than the lower limb. Synonychia has not been reported in the toes [<a class="bk_pop" href="#apert.REF.upton.1991.321">Upton 1991</a>, <a class="bk_pop" href="#apert.REF.cohen.1995.94">Cohen &#x00026; Kreiborg 1995</a>, <a class="bk_pop" href="#apert.REF.wilkie.1995.165">Wilkie et al 1995</a>].</p><p><b>Other limb anomalies</b> that occur less frequently in individuals with Apert syndrome include the following [<a class="bk_pop" href="#apert.REF.maroteaux.1987.153">Maroteaux &#x00026; Fonfria 1987</a>, <a class="bk_pop" href="#apert.REF.sidhu.1988.179">Sidhu &#x00026; Deshmukh 1988</a>, <a class="bk_pop" href="#apert.REF.gorlin.1989.557">Gorlin 1989</a>, <a class="bk_pop" href="#apert.REF.lefort.1992.107">Lefort et al 1992</a>, <a class="bk_pop" href="#apert.REF.cohen.1995.94">Cohen &#x00026; Kreiborg 1995</a>, <a class="bk_pop" href="#apert.REF.mantillacapacho.2005.403">Mantilla-Capacho et al 2005</a>]:</p><ul><li class="half_rhythm"><div>Synostosis of the radius and humerus</div></li><li class="half_rhythm"><div>Preaxial and/or postaxial polydactyly of the hands and/or feet</div></li><li class="half_rhythm"><div>Broad distal phalanx of the thumb or broad distal hallux</div></li></ul><p><b>Spinal fusions.</b> Cervical vertebral fusions are found in 68% of individuals with Apert syndrome, most commonly involving C5-C6. Of those with fusions, approximately 50% have a single fusion and 50% have multiple fusions. The prevalence and location of vertebral fusions differs from Crouzon syndrome, in which only 25% have vertebral fusion, most commonly involving C2-C3. If spinal fusions or abnormalities of spinal fusion occur, scoliosis can result [<a class="bk_pop" href="#apert.REF.kreiborg.1992.704">Kreiborg et al 1992</a>]. Other cervical spine anomalies include atlanto-axial subluxation (7%) and C1 spina bifida occulta (7%) [<a class="bk_pop" href="#apert.REF.breik.2016.833">Breik et al 2016</a>].</p><p><b>Progressive synostosis.</b> Progressive fusion of several bones may occur, including bones of the skull, hands, feet, carpus, tarsus, and cervical vertebrae [<a class="bk_pop" href="#apert.REF.schauerte.1966.67">Schauerte &#x00026; St-Aubin 1966</a>].</p><p>Restriction of movement involving the shoulder due to glenohumeral dysplasia can lead to functional impairment. This restriction tends to be progressive with decrease in forward flexion and abduction of the upper arm limiting the ability of the individual with Apert syndrome to perform "overhead" tasks [<a class="bk_pop" href="#apert.REF.mchugh.2007.596">McHugh et al 2007</a>, <a class="bk_pop" href="#apert.REF.murnaghan.2007.838">Murnaghan et al 2007</a>].</p><p>Children with Apert syndrome may experience progressive deformities of the foot leading to pain and difficulty with gait. Over time the first metatarsal bone becomes relatively short with resultant shift in the weight-bearing function of the first metatarsal to the second metatarsal bone, and the great toes become increasingly short and angulated. Callus formation develops as weight is redistributed laterally leading to pain and limitation of daily activities. Affected individuals experience difficulty finding footwear that fits properly [<a class="bk_pop" href="#apert.REF.calis.2016.582">Calis et al 2016</a>].</p><p><b>Neurologic.</b> Jugular foraminal stenosis is seen in 93% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p><p>Approximately 60% of individuals with Apert syndrome have nonprogressive ventriculomegaly and 6%-13% have hydrocephalus.</p><ul><li class="half_rhythm"><div>Stable ventriculomegaly does not necessarily require surgical intervention.</div></li><li class="half_rhythm"><div>Progressive ventriculomegaly can indicate hydrocephalus, which may require evaluation for endoscopic third ventriculostomy and/or ventriculoperitoneal shunt.</div></li></ul><p>Structural brain malformations in Apert syndrome include the following [<a class="bk_pop" href="#apert.REF.cohen.1990.36">Cohen &#x00026; Kreiborg 1990</a>, <a class="bk_pop" href="#apert.REF.cinalli.1995.575">Cinalli et al 1995</a>, <a class="bk_pop" href="#apert.REF.renier.1996.66">Renier et al 1996</a>, <a class="bk_pop" href="#apert.REF.quinterorivera.2006.1337">Quintero-Rivera et al 2006</a>, <a class="bk_pop" href="#apert.REF.tan.2018.205">Tan &#x00026; Mankad 2018</a>]:</p><ul><li class="half_rhythm"><div class="half_rhythm">Abnormalities of the corpus callosum (23%)</div></li><li class="half_rhythm"><div class="half_rhythm">Absent septum pellucidum (17%)</div></li><li class="half_rhythm"><div class="half_rhythm">Chiari I malformation and/or low-lying cerebellar tonsils (17%)</div><div class="half_rhythm">Note: Only 2% of individuals with Apert syndrome were found to have chronic tonsillar herniation, which is present in 73% of those with Crouzon syndrome.</div></li><li class="half_rhythm"><div class="half_rhythm">Posterior fossa arachnoid cyst (7%)</div></li><li class="half_rhythm"><div class="half_rhythm">Limbic malformations</div></li></ul><p><b>Neurodevelopment.</b> Most individuals with Apert syndrome have normal intellect or mild intellectual disability, though some individuals have been reported with moderate-to-severe intellectual disability [<a class="bk_pop" href="#apert.REF.renier.1996.66">Renier et al 1996</a>, <a class="bk_pop" href="#apert.REF.david.2016.1125">David et al 2016</a>, <a class="bk_pop" href="#apert.REF.fernandes.2016.1532">Fernandes et al 2016</a>]. Not surprisingly, children with Apert syndrome raised within the family have better cognitive outcomes than children who were institutionalized [<a class="bk_pop" href="#apert.REF.patton.1988.164">Patton et al 1988</a>, <a class="bk_pop" href="#apert.REF.cohen.1990.36">Cohen &#x00026; Kreiborg 1990</a>, <a class="bk_pop" href="#apert.REF.renier.1996.66">Renier et al 1996</a>]. The neurodevelopmental outcomes for children born with Apert syndrome today may be more promising than these earlier reports suggest, as surgical and medical management have become more advanced and children have improved access to early intervention programs.</p><p>Factors associated with a higher risk for intellectual disability include the following:</p><ul><li class="half_rhythm"><div>Delay of first craniectomy until after one year of age</div></li><li class="half_rhythm"><div>Presence of structural brain malformations</div><ul><li class="half_rhythm"><div>Abnormalities of the septum pellicudum have been shown to be associated with lower IQ.</div></li><li class="half_rhythm"><div>Data regarding the possible impact on IQ of an abnormal callosum and/or corpus callosum are conflicting.</div></li></ul></li></ul><p><b>Cardiovascular.</b> Approximately 10% of individuals with Apert syndrome have structural cardiac abnormalities. The most common malformations include ventricular septal defect and overriding aorta; some children with complex <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease have been reported. Children with complex congenital heart disease are at greater risk for early death compared to children with structurally normal hearts [<a class="bk_pop" href="#apert.REF.cohen.1993.758">Cohen &#x00026; Kreiborg 1993</a>].</p><p><b>Gastrointestinal issues.</b> Feeding difficulties can occur in Apert syndrome for a variety of reasons, and may require placement of a nasogastric or gastric tube.</p><p>One of 15 individuals with Apert syndrome had intestinal malrotation in one study, though it was unclear whether the remaining <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals had undergone formal radiologic evaluation for malrotation (upper GI); therefore, the true prevalence may be higher than reported [<a class="bk_pop" href="#apert.REF.hibberd.2016.3215">Hibberd et al 2016</a>].</p><p>Distal esophageal stenosis has also been reported [<a class="bk_pop" href="#apert.REF.pelz.1994.91">Pelz et al 1994</a>].</p><p>Other gastrointestinal malformations reported in Apert syndrome include the following:</p><ul><li class="half_rhythm"><div>Pyloric stenosis</div></li><li class="half_rhythm"><div>Esophageal atresia</div></li><li class="half_rhythm"><div>Ectopic anus</div></li></ul><p><b>Genitourinary.</b> Anomalies of the genitourinary tract are identified in 9.6% of children with Apert syndrome, most commonly hydronephrosis or cryptorchidism. One child with Apert syndrome due to a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>FGFR2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> had a low-grade papillary urothelial carcinoma of the bladder, but no detected <i>FGFR3</i> somatic variants (which can be associated with this type of cancer). As a single case was reported, it is unclear whether this is part of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of Apert syndrome [<a class="bk_pop" href="#apert.REF.cohen.1993.758">Cohen &#x00026; Kreiborg 1993</a>, <a class="bk_pop" href="#apert.REF.andreou.2006.2245">Andreou et al 2006</a>].</p><p><b>Skin changes.</b> Hyperhidrosis is a consistent feature of Apert syndrome. Affected adults typically develop oily skin in adolescence and extensive acneiform lesions, including on the face, chest, back, and upper arms. Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals develop excessive skin wrinkling of the forehead [<a class="bk_pop" href="#apert.REF.cohen.1995.94">Cohen &#x00026; Kreiborg 1995</a>]. Nail dystrophy is also common [<a class="bk_pop" href="#apert.REF.bissacotti_steglich.2016.e596">Bissacotti Steglich et al 2016</a>].</p><p><b>Adults.</b> A range of educational and employment ascertainment has been described. Adults with Apert syndrome appear to have more challenges with social development and relationships compared to unaffected controls and individuals with Crouzon syndrome [<a class="bk_pop" href="#apert.REF.tovetj_rn.2012.572e">Tovetj&#x000e4;rn et al 2012</a>, <a class="bk_pop" href="#apert.REF.david.2016.1125">David et al 2016</a>, <a class="bk_pop" href="#apert.REF.lloyd.2016.1510">Lloyd et al 2016</a>].</p></div><div id="apert.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Reports regarding <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> in Apert syndrome are variable. Some studies suggest no clear correlations [<a class="bk_pop" href="#apert.REF.park.1995.321">Park et al 1995</a>].</p><ul><li class="half_rhythm"><div><b>Pathogenic</b>
<a class="figpopup" href="/books/NBK541728/table/apert.T.fgfr2_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figapertTfgfr2pathogenicvariantsdiscus" rid-ob="figobapertTfgfr2pathogenicvariantsdiscus"><b>p.Pro253Arg</b></a>
<b>variant</b></div><ul><li class="half_rhythm"><div>Some studies have suggested more significant hand and foot involvement in individuals with this <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>One study suggested better postsurgical craniofacial appearance in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with this variant, but the generalizability of this study is limited due to significant evolution of surgical techniques since the study was published [<a class="bk_pop" href="#apert.REF.von_gernet.2000.137">von Gernet et al 2000</a>].</div></li></ul></li><li class="half_rhythm"><div><b>Pathogenic</b>
<a class="figpopup" href="/books/NBK541728/table/apert.T.fgfr2_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figapertTfgfr2pathogenicvariantsdiscus" rid-ob="figobapertTfgfr2pathogenicvariantsdiscus"><b>p.Ser252Trp</b></a>
<b>variant.</b> Cleft palate has been reported to be more common in those with this variant.</div></li></ul><p>No other features of Apert syndrome have been found to vary based on <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> [<a class="bk_pop" href="#apert.REF.slaney.1996.923">Slaney et al 1996</a>, <a class="bk_pop" href="#apert.REF.lajeunie.1999.443">Lajeunie et al 1999</a>].</p></div><div id="apert.Nomenclature"><h3>Nomenclature</h3><p>Apert syndrome may also be referred to as acrocephalysyndactyly type I.</p></div><div id="apert.Prevalence"><h3>Prevalence</h3><p>The estimated birth prevalence of Apert syndrome ranges from 1: 80,000 to 1:160,000 live births [<a class="bk_pop" href="#apert.REF.cohen.1992.655">Cohen et al 1992</a>, <a class="bk_pop" href="#apert.REF.tolarova.1997.394">Tolarova et al 1997</a>]. The frequency may be higher among children born to fathers with advanced paternal age, with the greatest number of variants in sperm from fathers older than age 60 years [<a class="bk_pop" href="#apert.REF.glaser.2003.939">Glaser et al 2003</a>].</p></div></div><div id="apert.Genetically_Related_Allelic_Disord"><h2 id="_apert_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>Other phenotypes associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <b><i>FGFR2</i></b> are summarized in <a class="figpopup" href="/books/NBK541728/table/apert.T.allelic_disorders_to_consider_in/?report=objectonly" target="object" rid-figpopup="figapertTallelicdisorderstoconsiderin" rid-ob="figobapertTallelicdisorderstoconsiderin">Tables 2a</a> and <a class="figpopup" href="/books/NBK541728/table/apert.T.other_allelic_disorders_not_in_t/?report=objectonly" target="object" rid-figpopup="figapertTotherallelicdisordersnotint" rid-ob="figobapertTotherallelicdisordersnotint">2b</a>. Disorders included in <a class="figpopup" href="/books/NBK541728/table/apert.T.allelic_disorders_to_consider_in/?report=objectonly" target="object" rid-figpopup="figapertTallelicdisorderstoconsiderin" rid-ob="figobapertTallelicdisorderstoconsiderin">Table 2a</a> have phenotypic features that overlap with Apert syndrome and should be considered in the differential diagnosis.</p><div id="apert.T.allelic_disorders_to_consider_in" class="table"><h3><span class="label">Table 2a. </span></h3><div class="caption"><p>Allelic Disorders to Consider in the Differential Diagnosis of Apert Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541728/table/apert.T.allelic_disorders_to_consider_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__apert.T.allelic_disorders_to_consider_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Allelic Disorder</th><th id="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_2" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Features of Allelic Disorder</th></tr><tr><th headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_3" id="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">In common with "classic" Apert syndrome</th><th headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_3" id="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not seen in Apert syndrome</th></tr></thead><tbody><tr><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR2</i>-related<br />Antley-Bixler<br />syndrome&#x000a0;<sup>1</sup></td><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_3 hd_h_apert.T.allelic_disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Craniosynostosis (coronal &#x00026; lambdoidal)</div></li><li class="half_rhythm"><div>Brachyturricephaly w/frontal bossing</div></li><li class="half_rhythm"><div>Ocular proptosis</div></li><li class="half_rhythm"><div>Downslanting palpebral fissures</div></li><li class="half_rhythm"><div>Radiohumeral synostosis</div></li></ul>
</td><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_3 hd_h_apert.T.allelic_disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Depression of nasal bridge</div></li><li class="half_rhythm"><div>Low-set, protruding ears</div></li><li class="half_rhythm"><div>Medial bowing of ulnae</div></li><li class="half_rhythm"><div>Bowing of femurs</div></li><li class="half_rhythm"><div>Slender hands &#x00026; feet</div></li><li class="half_rhythm"><div>Contractures at proximal IP joints</div></li><li class="half_rhythm"><div>Fractures</div></li><li class="half_rhythm"><div>Advanced bone age</div></li><li class="half_rhythm"><div>Congenital heart disease</div></li><li class="half_rhythm"><div>Renal anomalies</div></li><li class="half_rhythm"><div>Abnormalities of female genitalia</div></li><li class="half_rhythm"><div>Signs of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> adrenal hyperplasia</div></li></ul>
</td></tr><tr><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Beare-<br />Stevenson<br />syndrome&#x000a0;<sup>2</sup></td><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_3 hd_h_apert.T.allelic_disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Craniosynostosis (coronal most common)</div></li><li class="half_rhythm"><div>Midface hypoplasia</div></li></ul>
</td><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_3 hd_h_apert.T.allelic_disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Natal teeth</div></li><li class="half_rhythm"><div>Pyloric stenosis</div></li><li class="half_rhythm"><div>Furrowed palms &#x00026; soles</div></li><li class="half_rhythm"><div>Widespread cutis gyrata</div></li><li class="half_rhythm"><div>Acanthosis nigricans</div></li><li class="half_rhythm"><div>Skin tags</div></li><li class="half_rhythm"><div>Prominent umbilicus</div></li><li class="half_rhythm"><div>Accessory nipples</div></li><li class="half_rhythm"><div>Bifid scrotum</div></li><li class="half_rhythm"><div>Prominent labial raphe</div></li><li class="half_rhythm"><div>Rugated labia majora</div></li></ul>
</td></tr><tr><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Crouzon syndrome&#x000a0;<sup>2</sup></td><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_3 hd_h_apert.T.allelic_disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Craniosynostosis (multisuture, coronal most common)</div></li><li class="half_rhythm"><div>Brachyturricephaly</div></li><li class="half_rhythm"><div>Maxillary hypoplasia</div></li><li class="half_rhythm"><div>Obstructive sleep apnea</div></li><li class="half_rhythm"><div>Tracheal cartilaginous sleeve</div></li><li class="half_rhythm"><div>Hypertelorism</div></li><li class="half_rhythm"><div>Ocular proptosis</div></li><li class="half_rhythm"><div>Papilledema</div></li><li class="half_rhythm"><div>Strabismus</div></li><li class="half_rhythm"><div>Atresia of auditory canals</div></li><li class="half_rhythm"><div>Conductive hearing loss</div></li><li class="half_rhythm"><div>Hydrocephalus</div></li><li class="half_rhythm"><div>Cervical spine fusions</div></li></ul>
</td><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_3 hd_h_apert.T.allelic_disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Chiari 1 malformation more common</div></li><li class="half_rhythm"><div>Midface retrusion w/less vertical impaction</div></li></ul>
</td></tr><tr><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Jackson-Weiss syndrome&#x000a0;<sup>2</sup></td><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_3 hd_h_apert.T.allelic_disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Craniosynostosis (coronal most common)</div></li><li class="half_rhythm"><div>Maxillary hypoplasia</div></li><li class="half_rhythm"><div>Obstructive sleep apnea</div></li><li class="half_rhythm"><div>Hypertelorism</div></li><li class="half_rhythm"><div>Ocular proptosis</div></li><li class="half_rhythm"><div>Strabismus</div></li></ul>
</td><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_3 hd_h_apert.T.allelic_disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Radiographic abnormalities of the foot incl:
<ul><li class="half_rhythm"><div>Fusion of tarsal &#x00026; metatarsal bones</div></li><li class="half_rhythm"><div>2-3 syndactyly</div></li><li class="half_rhythm"><div>Broad &#x00026; medially deviated great toes</div></li><li class="half_rhythm"><div>Short 1st metatarsals</div></li><li class="half_rhythm"><div>Broad proximal phalanges</div></li></ul>
</td></tr><tr><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pfeiffer syndrome types 1, 2, &#x00026; 3&#x000a0;<sup>2</sup></td><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_3 hd_h_apert.T.allelic_disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Craniosynostosis (multisuture, coronal most common)</div></li><li class="half_rhythm"><div>Brachyturricephaly</div></li><li class="half_rhythm"><div>Maxillary hypoplasia</div></li><li class="half_rhythm"><div>Obstructive sleep apnea</div></li><li class="half_rhythm"><div>Tracheal cartilaginous sleeve</div></li><li class="half_rhythm"><div>Hypertelorism</div></li><li class="half_rhythm"><div>Ocular proptosis</div></li><li class="half_rhythm"><div>Papilledema</div></li><li class="half_rhythm"><div>Strabismus</div></li><li class="half_rhythm"><div>Downslanting palpebral fissures</div></li><li class="half_rhythm"><div>Atresia of auditory canals</div></li><li class="half_rhythm"><div>Conductive hearing loss</div></li><li class="half_rhythm"><div>Hydrocephalus</div></li><li class="half_rhythm"><div>Cervical spine fusions</div></li><li class="half_rhythm"><div>Radiohumeral fusions</div></li></ul>
</td><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_3 hd_h_apert.T.allelic_disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Chiari 1 malformation more common</div></li><li class="half_rhythm"><div>Broad &#x00026; deviated thumbs &#x00026; great toes</div></li><li class="half_rhythm"><div>Brachydactyly</div></li></ul>
</td></tr><tr><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR2</i>-related Saethre-Chotzen syndrome&#x000a0;<sup>3</sup></td><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_3 hd_h_apert.T.allelic_disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Craniosynostosis (unilateral or bilateral coronal)</div></li><li class="half_rhythm"><div>Brachyturricephaly</div></li><li class="half_rhythm"><div>Maxillary hypoplasia</div></li><li class="half_rhythm"><div>Obstructive sleep apnea</div></li><li class="half_rhythm"><div>High-arched palate</div></li><li class="half_rhythm"><div>Hypertelorism</div></li><li class="half_rhythm"><div>Downslanting palpebral fissures</div></li><li class="half_rhythm"><div>Hearing loss</div></li></ul>
</td><td headers="hd_h_apert.T.allelic_disorders_to_consider_in_1_1_1_3 hd_h_apert.T.allelic_disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Ptosis</div></li><li class="half_rhythm"><div>Facial asymmetry</div></li><li class="half_rhythm"><div>Low anterior hairline</div></li><li class="half_rhythm"><div>Parietal foramina</div></li><li class="half_rhythm"><div>Characteristic ear (small pinna w/a prominent crus)</div></li><li class="half_rhythm"><div>Partial 2-3 syndactyly of fingers</div></li><li class="half_rhythm"><div>Duplicated distal phalanx of hallux</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="apert.TF.2a.1"><p class="no_margin">Antley-Bixler syndrome is caused by mutation of <i>FGFR2</i> or <i>POR</i> (Note: <a href="/books/n/gene/abs/"><i>POR</i>-related Antley-Bixler syndrome</a> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div></dd><dt>2. </dt><dd><div id="apert.TF.2a.2"><p class="no_margin">See <a href="/books/n/gene/craniosynostosis/"><i>FGFR</i>-Related Craniosynostosis Syndromes</a>.</p></div></dd><dt>3. </dt><dd><div id="apert.TF.2a.3"><p class="no_margin">See <a href="/books/n/gene/scs/">Saethre-Chotzen Syndrome</a>. Saethre-Chotzen syndrome is typically caused by mutation of <i>TWIST1</i>, but a family with phenotypic features of Saethre-Chotzen syndrome and normal <i>TWIST1</i> <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> had an <i>FGFR2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#apert.REF.freitas.2006.142">Freitas et al 2006</a>].</p></div></dd></dl></div></div></div><div id="apert.T.other_allelic_disorders_not_in_t" class="table"><h3><span class="label">Table 2b. </span></h3><div class="caption"><p>Other Allelic Disorders (not in the Differential Diagnosis of Apert Syndrome)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541728/table/apert.T.other_allelic_disorders_not_in_t/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__apert.T.other_allelic_disorders_not_in_t_lrgtbl__"><table><thead><tr><th id="hd_h_apert.T.other_allelic_disorders_not_in_t_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phenotype</th><th id="hd_h_apert.T.other_allelic_disorders_not_in_t_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">References (<i>GeneReview</i>, OMIM, or Citation)</th></tr></thead><tbody><tr><td headers="hd_h_apert.T.other_allelic_disorders_not_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bent-bone dysplasia syndrome</td><td headers="hd_h_apert.T.other_allelic_disorders_not_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="https://omim.org/entry/614592" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614592</a></td></tr><tr><td headers="hd_h_apert.T.other_allelic_disorders_not_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Craniofacial-skeletal-dermatologic dysplasia</td><td headers="hd_h_apert.T.other_allelic_disorders_not_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="https://omim.org/entry/101600" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">101600</a></td></tr><tr><td headers="hd_h_apert.T.other_allelic_disorders_not_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR2</i>-related <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> coronal synostosis</td><td headers="hd_h_apert.T.other_allelic_disorders_not_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/craniosynostosis/"><i>FGFR</i>-Related Craniosynostosis Syndromes</a></td></tr><tr><td headers="hd_h_apert.T.other_allelic_disorders_not_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lacrimoauriculodentodigital (LADD) syndrome</td><td headers="hd_h_apert.T.other_allelic_disorders_not_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="https://omim.org/entry/149730" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">149730</a></td></tr><tr><td headers="hd_h_apert.T.other_allelic_disorders_not_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Syndromic craniosynostosis with elbow contracture</td><td headers="hd_h_apert.T.other_allelic_disorders_not_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#apert.REF.akai.2006.108">Akai et al 2006</a></td></tr><tr><td headers="hd_h_apert.T.other_allelic_disorders_not_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Scaphocephaly, maxillary retrusion, and intellectual disability</td><td headers="hd_h_apert.T.other_allelic_disorders_not_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="https://omim.org/entry/609579" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609579</a></td></tr></tbody></table></div></div><p>Sporadic tumors (including gastric cancer) occurring as single tumors in the absence of any other findings of Apert syndrome frequently harbor somatic variants in <i>FGFR2</i> that are <b>not</b> present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>. In these circumstances predisposition to these tumors is not heritable. For more details, see <a href="#apert.Cancer_and_Benign_Tumors">Cancer and Benign Tumors</a>.</p></div><div id="apert.Differential_Diagnosis"><h2 id="_apert_Differential_Diagnosis_">Differential Diagnosis</h2><p>Most children with multisuture synostosis will have a <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> form of craniosynostosis. The presence of specific craniofacial characteristics and hand and foot anomalies allow for the clinical diagnosis of Apert syndrome in most cases. Establishing an accurate diagnosis has important implications for screening, surveillance, management, and counseling (see <a href="#apert.Management">Management</a> and <a href="#apert.Genetic_Counseling">Genetic Counseling</a>).</p><p>Select syndromes to consider in the differential diagnosis of Apert syndrome include the allelic disorders listed in <a class="figpopup" href="/books/NBK541728/table/apert.T.allelic_disorders_to_consider_in/?report=objectonly" target="object" rid-figpopup="figapertTallelicdisorderstoconsiderin" rid-ob="figobapertTallelicdisorderstoconsiderin">Table 2a</a> (<i>FGFR2</i>-related Antley-Bixler syndrome, Beare-Stevenson syndrome, Crouzon syndrome, Jackson-Weiss syndrome, Pfeiffer syndrome types 1, 2, and 3, <i>FGFR2</i>-related Saethre-Chotzen syndrome) and the select syndromes listed in <a class="figpopup" href="/books/NBK541728/table/apert.T.nonallelic_craniosynostosis_synd/?report=objectonly" target="object" rid-figpopup="figapertTnonalleliccraniosynostosissynd" rid-ob="figobapertTnonalleliccraniosynostosissynd">Table 3</a>.</p><div id="apert.T.nonallelic_craniosynostosis_synd" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Nonallelic Craniosynostosis Syndromes to Consider in the Differential Diagnosis of Apert Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541728/table/apert.T.nonallelic_craniosynostosis_synd/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__apert.T.nonallelic_craniosynostosis_synd_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_2" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Features of the Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_4" id="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">In common with "classic" Apert syndrome</th><th headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_4" id="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not seen in Apert syndrome</th></tr></thead><tbody><tr><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>POR</i></td><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>POR</i>-related <a href="/books/n/gene/abs/">Antley-Bixler syndrome&#x000a0;</a><sup>1</sup></td><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_4 hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <a class="figpopup" href="/books/NBK541728/table/apert.T.allelic_disorders_to_consider_in/?report=objectonly" target="object" rid-figpopup="figapertTallelicdisorderstoconsiderin" rid-ob="figobapertTallelicdisorderstoconsiderin">Table 2a</a></td><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_4 hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <a class="figpopup" href="/books/NBK541728/table/apert.T.allelic_disorders_to_consider_in/?report=objectonly" target="object" rid-figpopup="figapertTallelicdisorderstoconsiderin" rid-ob="figobapertTallelicdisorderstoconsiderin">Table 2a</a></td></tr><tr><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RAB23</i></td><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Carpenter syndrome</td><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_4 hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Craniosynostosis (multisuture, coronal most common)</div></li><li class="half_rhythm"><div>Brachyturricephaly</div></li><li class="half_rhythm"><div>Maxillary hypoplasia</div></li><li class="half_rhythm"><div>Obstructive sleep apnea</div></li><li class="half_rhythm"><div>Hypertelorism</div></li><li class="half_rhythm"><div>Ocular proptosis</div></li></ul>
</td><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_4 hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Brachydactyly w/out syndactyly</td></tr><tr><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR3</i></td><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/muenke/">Muenke syndrome</a></td><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_4 hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Craniosynostosis (unilateral or bilateral coronal)</div></li><li class="half_rhythm"><div>Mild maxillary hypoplasia</div></li><li class="half_rhythm"><div>Downslanting palpebral fissures</div></li><li class="half_rhythm"><div>Cervical spine fusions</div></li></ul>
</td><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_4 hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Sensorineural hearing loss</div></li><li class="half_rhythm"><div>Brachydactyly</div></li><li class="half_rhythm"><div>Carpal-tarsal fusion</div></li><li class="half_rhythm"><div>Carpal bone malsegregation</div></li><li class="half_rhythm"><div>Coned epiphyses</div></li></ul>
</td></tr><tr><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR1</i></td><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FGFR1</i>-related Pfeiffer syndrome types 1, 2, &#x00026; 3&#x000a0;<sup>2</sup></td><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_4 hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <a class="figpopup" href="/books/NBK541728/table/apert.T.allelic_disorders_to_consider_in/?report=objectonly" target="object" rid-figpopup="figapertTallelicdisorderstoconsiderin" rid-ob="figobapertTallelicdisorderstoconsiderin">Table 2a</a></td><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_4 hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <a class="figpopup" href="/books/NBK541728/table/apert.T.allelic_disorders_to_consider_in/?report=objectonly" target="object" rid-figpopup="figapertTallelicdisorderstoconsiderin" rid-ob="figobapertTallelicdisorderstoconsiderin">Table 2a</a></td></tr><tr><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TWIST1</i></td><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TWIST1</i>-related <a href="/books/n/gene/scs/">Saethre-Chotzen syndrome&#x000a0;</a><sup>3</sup></td><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_4 hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <a class="figpopup" href="/books/NBK541728/table/apert.T.allelic_disorders_to_consider_in/?report=objectonly" target="object" rid-figpopup="figapertTallelicdisorderstoconsiderin" rid-ob="figobapertTallelicdisorderstoconsiderin">Table 2a</a></td><td headers="hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_1_4 hd_h_apert.T.nonallelic_craniosynostosis_synd_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <a class="figpopup" href="/books/NBK541728/table/apert.T.allelic_disorders_to_consider_in/?report=objectonly" target="object" rid-figpopup="figapertTallelicdisorderstoconsiderin" rid-ob="figobapertTallelicdisorderstoconsiderin">Table 2a</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="apert.TF.3.1"><p class="no_margin">Antley-Bixler syndrome is caused by mutation of <i>FGFR2</i> or <i>POR</i>.</p></div></dd><dt>2. </dt><dd><div id="apert.TF.3.2"><p class="no_margin">Pfeiffer syndrome is caused by mutation of <i>FGFR1</i> or <i>FGFR2</i>. See <a href="/books/n/gene/craniosynostosis/"><i>FGFR</i>-Related Craniosynostosis Syndromes</a>.</p></div></dd><dt>3. </dt><dd><div id="apert.TF.3.3"><p class="no_margin">Saethre-Chotzen syndrome is typically caused by mutation of <i>TWIST1</i>, but a family with phenotypic features of Saethre-Chotzen syndrome and normal <i>TWIST1</i> <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> had an <i>FGFR2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#apert.REF.freitas.2006.142">Freitas et al 2006</a>].</p></div></dd></dl></div></div></div></div><div id="apert.Management"><h2 id="_apert_Management_">Management</h2><div id="apert.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Apert syndrome, the evaluations summarized in <a class="figpopup" href="/books/NBK541728/table/apert.T.recommended_evaluations_followin/?report=objectonly" target="object" rid-figpopup="figapertTrecommendedevaluationsfollowin" rid-ob="figobapertTrecommendedevaluationsfollowin">Table 4</a> (if not performed already) are recommended.</p><div id="apert.T.recommended_evaluations_followin" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with Apert Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541728/table/apert.T.recommended_evaluations_followin/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__apert.T.recommended_evaluations_followin_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_apert.T.recommended_evaluations_followin_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/<br />Concern</th><th id="hd_h_apert.T.recommended_evaluations_followin_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_apert.T.recommended_evaluations_followin_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Craniofacial</b></td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Physical examination to identify cleft palate, ear anomalies, face shape, fontanelles, suture ridging, &#x00026; skull base symmetry</td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessing degree of maxillary hypoplasia is important for determining risk for airway compromise.</td></tr><tr><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/pediatric ophthalmologist&#x000a0;<sup>1</sup></td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incl assessment of eye surfaces, eye alignment, &#x00026; optic nerves</td></tr><tr><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ears</b></td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ear-specific hearing evaluation</td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess for airway symptoms (snoring, stridor, apnea, respiratory distress)</td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Overnight polysomnography (sleep study)</td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To identify &#x00026; quantify degree of sleep apnea&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Consider consultation w/otolaryngologist &#x00026; sleep medicine</td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Airway endoscopy (flexible bedside endoscopy &#x00026; diagnostic laryngoscopy &#x00026; bronchoscopy) may help identify types &#x00026; degree of airway narrowing.&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiovascular</b></td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cardiac assessment</td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Echocardiogram if a murmur is present or there are clinical cardiac concerns</td></tr><tr><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal</b></td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Upper GI w/small bowel follow-through if symptomatic or during preoperative evaluation for gastrostomy tube</td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for intestinal malrotation</td></tr><tr><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Genitourinary</b></td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment for cryptorchidism in males</td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to urologist</td></tr><tr><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Renal ultrasound</td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for hydronephrosis</td></tr><tr><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CT scan of head/skull/sutures</td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CT w/3D reconstruction will delineate degree of suture involvement &#x00026; help w/preoperative planning.</td></tr><tr><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Cervical spine imaging to evaluate for vertebral fusions &#x00026; instability</td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CT of cervical spine before cranial surgery; or perform radiograph after age 2 yrs (when vertebrae are ossified)</td></tr><tr><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Hand radiographs to evaluate extent of syndactyly, which commonly includes bony fusion, or symphalangism</td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/hand surgeon</td></tr><tr><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CT scan or MRI of the head to evaluate for hydrocephalus &#x00026; CNS anomalies</td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If concern for hydrocephalus or Chiari malformation, consider brain MRI.</td></tr><tr><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other</b></td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment for developmental disabilities</td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to a neurodevelopmental specialist / early intervention services</td></tr><tr><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026; genetic counselor</td><td headers="hd_h_apert.T.recommended_evaluations_followin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To incl <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> counseling</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">CNS = central nervous system; CT = computed tomography; MRI = magnetic resonance imaging</p></div></dd><dt>1. </dt><dd><div id="apert.TF.4.1"><p class="no_margin">Early detection and management of amblyopia, encouraging timely decompressive surgery before the presence of optic nerve atrophy, and protection of the cornea are the management goals for ophthalmologists [<a class="bk_pop" href="#apert.REF.khong.2006a.328">Khong et al 2006a</a>].</p></div></dd><dt>2. </dt><dd><div id="apert.TF.4.2"><p class="no_margin"><a class="bk_pop" href="#apert.REF.inverso.2016.167">Inverso et al [2016]</a></p></div></dd><dt>3. </dt><dd><div id="apert.TF.4.3"><p class="no_margin"><a class="bk_pop" href="#apert.REF.doerga.2016.191">Doerga et al [2016]</a></p></div></dd></dl></div></div></div></div><div id="apert.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><div id="apert.T.treatment_of_manifestations_in_i" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with Apert Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541728/table/apert.T.treatment_of_manifestations_in_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__apert.T.treatment_of_manifestations_in_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/<br />Concern</th><th id="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Craniosynostosis</b></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In general, multisuture craniosynostosis should be surgically repaired in 1st yr of life.&#x000a0;<sup>1,&#x000a0;2,&#x000a0;3,&#x000a0;4</sup></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Specific timing guided by child's anatomy, risk for elevated intracranial pressure, &#x00026; respiratory status&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Midface</b><br /><b>retrusion</b></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Jaw surgery to advance the midface</td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Typically in childhood or adolescence&#x000a0;<sup>6,</sup>&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cleft palate</b></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Palate surgery is typically performed prior to development of pressure consonants.</td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To improve speech production &#x00026; intelligibility</td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Feeding/</b><br /><b>swallowing difficulties&#x000a0;<sup>8</sup></b></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Feeding therapy is helpful to evaluate swallowing safety &#x00026; support eating by mouth.</td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dental</b></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pediatric dental care &#x00026; evaluation by craniofacial orthodontist as part of coordinated craniofacial team care</td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Orthodontist plays an important role in determining type &#x00026; timing of orofacial interventions.</td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Strabismus</b></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Strabismus should be treated by ophthalmologist w/expertise in eye alignment in children w/craniosynostosis.</td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Amblyopia is a major cause of visual impairment.</td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing loss</b></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Placement of tympanostomy tubes</td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If chronic middle ear effusions are present</td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Hearing aids, bone conduction sound processors, tympanoplasties, &#x00026; aural atresia/stenosis repair</td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Optimizing hearing will facilitate language &#x00026; communication development.</td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Airway</b><br /><b>obstruction</b></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Awareness of potential airway compromise &#x00026; proactive airway management are crucial in infants &#x00026; children.</td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Specific airway management in Apert syndrome will depend on level &#x00026; severity of obstruction.</td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Temporizing measures to bypass airway obstruction:
<ul><li class="half_rhythm"><div>Placement of nasal stents</div></li><li class="half_rhythm"><div>Endotracheal intubation</div></li><li class="half_rhythm"><div>Tracheotomy</div></li></ul>
</td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Infants &#x00026; children requiring tracheotomy may also need positive pressure ventilation to normalize gas exchange &#x00026; achieve normal sleep &#x00026; growth.&#x000a0;<sup>9</sup></td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Sleep apnea</b></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Surgical interventions (adenoidectomy, nasal airway procedures, tracheostomy) are often helpful.</td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Avoid use of CPAP/BiPAP for long-term treatment of sleep apnea when possible because pressure on midface exacerbates midfacial retrusion.</td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Supplemental oxygen via nasal cannula is sometimes beneficial.</td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reducing sleep apnea &#x00026; improving sleep quality has the potential to improve learning, cognition, &#x00026; behavior.</td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Congenital heart defects</b></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per cardiologist</td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Malrotation</b></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per surgeon</td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cryptorchidism in males or hydronephrosis</b></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per urologist</td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Syndactyly</b></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Type &#x00026; timing of surgeries depends on presence of thumb syndactyly &#x00026; extent of soft tissue deficiency.</td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">A common goal: improve hand &#x00026; foot function w/fewest number of surgeries</td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Treatment can be separated into early phase (syndactyly releases) &#x00026; late phases (functional osteotomies).&#x000a0;<sup>10,&#x000a0;11</sup></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Most individuals require multiple procedures &#x00026; revisions throughout childhood.&#x000a0;<sup>12</sup></td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Scoliosis</b></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per orthopedist</td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Speech abnormalities&#x000a0;<sup>8</sup></b></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Speech evaluation by speech-language pathologist w/craniofacial expertise to guide speech therapy recommendations</td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Developmental delay</b></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early intervention services</td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider consultation w/developmental pediatrician or neurodevelopmental specialist.</td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Acne</b></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oral isotretinoin may be considered for those w/refractory acne not responsive to standard therapies.&#x000a0;<sup>13</sup></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oral isotretinoin is a known human teratogen &#x00026; should be not prescribed to females of childbearing age unless 2 independent forms of birth control are instituted &#x00026; monthly pregnancy tests performed.</td></tr><tr><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Emotional &#x00026; behavioral adjustment</b></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Psychosocial assessments &#x00026; mental health support throughout childhood&#x000a0;<sup>14</sup></td><td headers="hd_h_apert.T.treatment_of_manifestations_in_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Recognize &#x00026; address potential bullying/teasing by peers.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="apert.TF.5.1"><p class="no_margin">Cranioplasty involves release of fused sutures and repositioning and reconstruction of the calvaria, in order to prevent increased ICP and reduce progressive abnormal craniofacial development.</p></div></dd><dt>2. </dt><dd><div id="apert.TF.5.2"><p class="no_margin">Several techniques including endoscopic strip craniectomy, advancement through posterior distraction, and traditional cranioplasty are in current use.</p></div></dd><dt>3. </dt><dd><div id="apert.TF.5.3"><p class="no_margin">Early surgery may be performed to reduce intracranial pressure; however, young infants with Apert syndrome may have minimal reserve. Later surgeries tend to lead to a more stable bony correction [<a class="bk_pop" href="#apert.REF.taylor.2016.122e">Taylor &#x00026; Bartlett 2016</a>].</p></div></dd><dt>4. </dt><dd><div id="apert.TF.5.4"><p class="no_margin">A staged approach to increase intracranial volume and protect the globes is often pursued, and most children with Apert and bicoronal craniosynostosis will benefit from a front-orbital advancement.</p></div></dd><dt>5. </dt><dd><div id="apert.TF.5.5"><p class="no_margin">The goals of craniofacial surgery are to provide adequate intracranial volume to allow brain development and to improve skull shape. The timing and sequence of surgical interventions are dependent on the patient's functional, aesthetic, and psychological needs [<a class="bk_pop" href="#apert.REF.mccarthy.2012.1s">McCarthy et al 2012</a>].</p></div></dd><dt>6. </dt><dd><div id="apert.TF.5.6"><p class="no_margin">Timing of jaw surgery is guided by the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's occlusion and degree of airway obstruction.</p></div></dd><dt>7. </dt><dd><div id="apert.TF.5.7"><p class="no_margin">Compared with Le Fort III distraction, Le Fort II distraction with simultaneous repositioning of the zygomas improves the facial and orbital relationships for older children with Apert syndrome [<a class="bk_pop" href="#apert.REF.hopper.2013.129">Hopper et al 2013</a>].</p></div></dd><dt>8. </dt><dd><div id="apert.TF.5.8"><p class="no_margin">Articulation, resonance, language development, voice, feeding, and swallowing may be affected in individuals with Apert syndrome.</p></div></dd><dt>9. </dt><dd><div id="apert.TF.5.9"><p class="no_margin">Serious caution must be taken in the placement and care of tracheostomies in patients with tracheal cartilaginous sleeve malformation because of abnormal tissue healing and granulation tissue formation [<a class="bk_pop" href="#apert.REF.wenger.2017.62">Wenger et al 2017</a>].</p></div></dd><dt>10. </dt><dd><div id="apert.TF.5.10"><p class="no_margin"><a class="bk_pop" href="#apert.REF.fearon.2003.1">Fearon [2003]</a></p></div></dd><dt>11. </dt><dd><div id="apert.TF.5.11"><p class="no_margin">Recent studies describe novel techniques to improve aesthetic outcomes in children with complex syndactylies [<a class="bk_pop" href="#apert.REF.lohmeyer.2016.308">Lohmeyer et al 2016</a>].</p></div></dd><dt>12. </dt><dd><div id="apert.TF.5.12"><p class="no_margin"><a class="bk_pop" href="#apert.REF.pettitt.2017.223">Pettitt et al [2017]</a></p></div></dd><dt>13. </dt><dd><div id="apert.TF.5.13"><p class="no_margin">Evidence suggests that oral isotretinoin may be more effective than standard therapies, and biologic models support a role for isotretinoin in regulating androgens and <i>FGFR2</i> signaling [<a class="bk_pop" href="#apert.REF.melnik.2009.1868">Melnik et al 2009</a>].</p></div></dd><dt>14. </dt><dd><div id="apert.TF.5.14"><p class="no_margin">Suggested areas of focus include the parents' and family's emotional, social, and financial needs; the child's neurocognitive development and educational needs; and potential barriers to care [<a class="bk_pop" href="#apert.REF.mccarthy.2012.1s">McCarthy et al 2012</a>].</p></div></dd></dl></div></div></div><div id="apert.Developmental_Delay__Intellectual"><h4>Developmental Delay / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p><p><b>Ages 5-21 years</b></p><ul><li class="half_rhythm"><div>In the US, an IEP based on the individual's level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district until age 21.</div></li><li class="half_rhythm"><div>Discussion about transition plans including financial, vocation/employment, and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</div></li></ul><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="apert.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross and fine motor dysfunction.</b> Children with Apert syndrome have difficulty with the use of their hands for functions such as feeding, grooming, dressing, and writing. The goal of hand surgeries is to separate fingers to restore capacity for function to the hands. Most children with Apert will require therapy to maximize use of their hands secondary to polysyndactyly and fusions. Most individuals will have multiple hand surgeries, and physical and occupational therapy before and after surgery to maximize function. There is regional variation in whether these services are provided by physical therapy, occupational therapy, or a combination of the two.</p><p><b>Oral motor dysfunction.</b> Assuming that the individual is safe to eat by mouth, feeding therapy &#x02013; typically from an occupational or speech therapist &#x02013; is recommended for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have difficulty feeding due to poor oral motor control. In Apert syndrome, feeding difficulties often signal worsening upper-airway obstruction, so the therapist should be in communication with the craniofacial team to ensure that surgical intervention is not needed.</p></div><div id="apert.Adults"><h4>Adults</h4><p>Comprehensive care provided by a specialized craniofacial center that includes psychosocial support and holistic transition (to adult care) planning may improve quality of life for adults with Apert syndrome.</p></div></div><div id="apert.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><div id="apert.T.prevention_of_secondary_manifest" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Prevention of Secondary Manifestations in Individuals with Apert Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541728/table/apert.T.prevention_of_secondary_manifest/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__apert.T.prevention_of_secondary_manifest_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_apert.T.prevention_of_secondary_manifest_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Manifestation/Concern</th><th id="hd_h_apert.T.prevention_of_secondary_manifest_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Prevention</th><th id="hd_h_apert.T.prevention_of_secondary_manifest_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_apert.T.prevention_of_secondary_manifest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Papilledema / cognitive impairment</b></td><td headers="hd_h_apert.T.prevention_of_secondary_manifest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Timely surgical treatment of craniosynostosis</td><td headers="hd_h_apert.T.prevention_of_secondary_manifest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_apert.T.prevention_of_secondary_manifest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Exposure keratopathy &#x00026; corneal scarring due to ocular proptosis</b></td><td headers="hd_h_apert.T.prevention_of_secondary_manifest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ocular lubricants</td><td headers="hd_h_apert.T.prevention_of_secondary_manifest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitoring of eye surfaces, eye alignment, &#x00026; vision recommended to prevent &#x00026; reduce visual loss</td></tr><tr><td headers="hd_h_apert.T.prevention_of_secondary_manifest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Perioperative respiratory complications&#x000a0;<sup>1</sup></b></td><td headers="hd_h_apert.T.prevention_of_secondary_manifest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anesthesia evaluation before any surgical intervention for those w/potential airway challenges may improve communication &#x00026; outcomes.</td><td headers="hd_h_apert.T.prevention_of_secondary_manifest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Risks related to anesthesia higher in individuals w/Apert syndrome&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_apert.T.prevention_of_secondary_manifest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Aspiration pneumonia w/subsequent chronic lung disease</b></td><td headers="hd_h_apert.T.prevention_of_secondary_manifest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Aspiration precautions (e.g., thickened feeds, limiting oral intake)</td><td headers="hd_h_apert.T.prevention_of_secondary_manifest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical feeding evaluation &#x00026;/or video fluoroscopic swallowing study may help determine aspiration risk.</td></tr><tr><td headers="hd_h_apert.T.prevention_of_secondary_manifest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Spinal cord injury &#x00026; neurologic sequelae</b></td><td headers="hd_h_apert.T.prevention_of_secondary_manifest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Vigilance regarding spine precautions</div></li><li class="half_rhythm"><div>Consultation w/spine surgeon will guide precautions &#x00026; positioning prior to surgery &#x00026; anesthesia.</div></li></ul>
</td><td headers="hd_h_apert.T.prevention_of_secondary_manifest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In those w/cervical spine anomalies</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="apert.TF.6.1"><p class="no_margin">Most commonly upper-airway obstruction (6.1%) [<a class="bk_pop" href="#apert.REF.barnett.2011.72">Barnett et al 2011</a>]</p></div></dd><dt>2. </dt><dd><div id="apert.TF.6.2"><p class="no_margin">While upper-airway obstruction is the most common, lower respiratory-tract complications during anesthesia have also been reported [<a class="bk_pop" href="#apert.REF.elwood.2001.701">Elwood et al 2001</a>].</p></div></dd></dl></div></div></div></div><div id="apert.Surveillance"><h3>Surveillance</h3><p>A craniofacial team made up of the appropriate specialties allows for proper planning and coordination so that the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual may receive the best possible care [<a class="bk_pop" href="#apert.REF.mccarthy.2012.1s">McCarthy et al 2012</a>].</p><p>Ideally, the composition of the multidisciplinary team caring for a child with Apert syndrome should include the following specialists:</p><ul><li class="half_rhythm"><div>Audiologist</div></li><li class="half_rhythm"><div>Dentist</div></li><li class="half_rhythm"><div>Dermatologist</div></li><li class="half_rhythm"><div>Feeding specialist</div></li><li class="half_rhythm"><div>Geneticist</div></li><li class="half_rhythm"><div>Neurodevelopmental and behavioral pediatrician</div></li><li class="half_rhythm"><div>Neurosurgeon</div></li><li class="half_rhythm"><div>Nurse</div></li><li class="half_rhythm"><div>Nutritionist</div></li><li class="half_rhythm"><div>Ophthalmologist</div></li><li class="half_rhythm"><div>Oral surgeon</div></li><li class="half_rhythm"><div>Orthodontist</div></li><li class="half_rhythm"><div>Orthopedist (hand and foot surgery)</div></li><li class="half_rhythm"><div>Otolaryngologist</div></li><li class="half_rhythm"><div>Pediatrician</div></li><li class="half_rhythm"><div>Plastic surgeon</div></li><li class="half_rhythm"><div>Psychologist</div></li><li class="half_rhythm"><div>Pulmonologist / sleep medicine</div></li><li class="half_rhythm"><div>Social worker</div></li><li class="half_rhythm"><div>Speech pathologist</div></li><li class="half_rhythm"><div>Spine surgeon</div></li></ul><div id="apert.T.recommended_surveillance_for_ind" class="table"><h3><span class="label">Table 7. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with Apert Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541728/table/apert.T.recommended_surveillance_for_ind/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__apert.T.recommended_surveillance_for_ind_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Oropharynx</b></td><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment for velopharyngeal insufficiency&#x000a0;<sup>1,&#x000a0;2</sup></td><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">After emergence of language</td></tr><tr><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Speech assessment to monitor for speech disorders</td><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At least annually</td></tr><tr><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dental</b></td><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessments w/primary dentist to &#x02193; caries &#x00026; support dental health&#x000a0;<sup>3</sup></td><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Every 6 mos</td></tr><tr><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation to incl vision, eye alignment, &#x00026; dilated fundoscopy to assess optic nerves&#x000a0;<sup>4</sup></td><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually</td></tr><tr><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ears</b></td><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Audiologic &#x00026; otologic assessements</td><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At least annually</td></tr><tr><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitor for development of scoliosis by clinical exam w/surveillance spine radiographs if recommended by spine surgeon.</td><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually in childhood &#x00026; adolescence</td></tr><tr><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Measurements of head circumference (&#x00026; fontanelle size, if applicable) to monitor for progressive hydrocephalus</td><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">At each appointment in infancy &#x00026; early childhood</td></tr><tr><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Assessments for &#x02191;intracranial pressure&#x000a0;<sup>5,&#x000a0;6</sup></td></tr><tr><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Evaluation by craniofacial team</td><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Regularly, esp in infancy, childhood, &#x00026; adolescence</td></tr><tr><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Development/</b><br /><b>Cognition</b></td><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment of developmental progress</td><td headers="hd_h_apert.T.recommended_surveillance_for_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="apert.TF.7.1"><p class="no_margin">For those with cleft palate</p></div></dd><dt>2. </dt><dd><div id="apert.TF.7.2"><p class="no_margin">Orthognathic and airway procedures may also alter velopharyngeal function.</p></div></dd><dt>3. </dt><dd><div id="apert.TF.7.3"><p class="no_margin">Surveillance by an orthodontist with craniofacial expertise beginning in mixed dentition will help guide orthodontic and orthognathic interventions.</p></div></dd><dt>4. </dt><dd><div id="apert.TF.7.4"><p class="no_margin">Papilledema in individuals with multisuture craniosynostosis can occur before and after cranial decompression [<a class="bk_pop" href="#apert.REF.bannink.2008.121">Bannink et al 2008</a>].</p></div></dd><dt>5. </dt><dd><div id="apert.TF.7.5"><p class="no_margin">The type of surveillance needed depends on the types of surgery that the child has had and will be determined by the neurosurgeon and craniofacial team.</p></div></dd><dt>6. </dt><dd><div id="apert.TF.7.6"><p class="no_margin">The craniofacial team should be contacted urgently if there are symptoms that suggest increased pressure such as unexplained persistent vomiting, headaches, or changes in head circumference.</p></div></dd></dl></div></div></div></div><div id="apert.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Contact sports and activities that involve neck hyperflexion or extension should be avoided, unless the individual has had the cervical spine assessed and cleared.</p><p>Avoid factors that potentiate hearing loss (ototoxic medications, overly loud stimuli).</p><p>Use of CPAP/BiPAP for long-term treatment of sleep apnea should be avoided when possible because pressure on the midface will exacerbate midfacial retrusion.</p></div><div id="apert.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#apert.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="apert.Pregnancy_Management"><h3>Pregnancy Management</h3><p>No published studies address management of pregnancy in women with Apert syndrome.</p><ul><li class="half_rhythm"><div>Affected pregnant women should be monitored carefully for signs and symptoms of worsening obstructive sleep apnea.</div></li><li class="half_rhythm"><div>A pregnant woman with Apert syndrome should have a careful anesthesia evaluation prior to initiation of labor to determine whether multilevel airway anomalies or vertebral anomalies would result in additional risk with certain types of anesthesia.</div><ul><li class="half_rhythm"><div>If an obstetric emergency necessitates use of general anesthesia, fiberoptic intubation could be required.</div></li><li class="half_rhythm"><div>If this need were identified prior to delivery, the delivery location and timing could be chosen to ensure that adequate personnel were present to perform fiberoptic intubation, if needed.</div></li></ul></li></ul></div><div id="apert.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="apert.Genetic_Counseling"><h2 id="_apert_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="apert.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Apert syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="apert.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Some individuals diagnosed with Apert syndrome have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>Most individuals diagnosed with Apert syndrome have the disorder as the result of a <i>de novo FGFR2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant is unknown. Advanced paternal age has been shown clinically to be associated with <i>de novo</i> pathogenic variants for Apert syndrome [<a class="bk_pop" href="#apert.REF.moloney.1996.48">Moloney et al 1996</a>, <a class="bk_pop" href="#apert.REF.yoon.2009.e1000558">Yoon et al 2009</a>]. It has been proposed that <i>FGFR</i> pathogenic variants are paradoxically enriched in the male <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> because they confer a selective advantage to the spermatogonial cells in which they arise [<a class="bk_pop" href="#apert.REF.goriely.2003.643">Goriely et al 2003</a>, <a class="bk_pop" href="#apert.REF.choi.2008.10143">Choi et al 2008</a>, <a class="bk_pop" href="#apert.REF.bochukova.2009.204">Bochukova et al 2009</a>, <a class="bk_pop" href="#apert.REF.yoon.2009.e1000558">Yoon et al 2009</a>].</div></li><li class="half_rhythm"><div>Molecular genetic testing can be performed on the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; however; such testing is unlikely to provide additional information as the genetic status of the parents can be inferred based on their clinical status (Apert syndrome is 100% penetrant and therefore a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> parent will be clinically <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>).</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the pathogenic variant most likely occurred <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> in the proband. Another possible explanation is <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Parental germline mosaicism has been reported in a family with <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sisters born to unaffected parents [<a class="bk_pop" href="#apert.REF.allanson.1986.429">Allanson 1986</a>].</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to sibs is 50%.</div></li><li class="half_rhythm"><div>If the parents are unaffected and/or the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a known <i>FGFR2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is slightly greater than that of the general population because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#apert.REF.allanson.1986.429">Allanson 1986</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with Apert syndrome has a 50% chance of inheriting the <i>FGFR2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>FGFR2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="apert.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="apert.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Testing</h3><p>Once the <i>FGFR2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="apert.Resources"><h2 id="_apert_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Children's Craniofacial Association (CCA)</b></div><div>13140 Coit Road</div><div>Suite 517</div><div>Dallas TX 75240</div><div><b>Phone:</b> 800-535-3643 (toll-free); 214-570-9099</div><div><b>Fax:</b> 214-570-8811</div><div><b>Email:</b> contactCCA@ccakids.com</div><div><a href="http://www.ccakids.org/apert-syndrome.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">A Guide to Understanding Apert Syndrome</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=apertsyndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Apert syndrome</a></div></li></ul></div><div id="apert.Molecular_Genetics"><h2 id="_apert_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="apert.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Apert Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541728/table/apert.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__apert.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_apert.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_apert.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_apert.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_apert.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_apert.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_apert.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_apert.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2263" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FGFR2</i></a></td><td headers="hd_b_apert.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2263" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">10q26<wbr style="display:inline-block"></wbr>​.13</a></td><td headers="hd_b_apert.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P21802" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Fibroblast growth factor receptor 2</a></td><td headers="hd_b_apert.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/FGFR2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGFR2 @ LOVD</a></td><td headers="hd_b_apert.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FGFR2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGFR2</a></td><td headers="hd_b_apert.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FGFR2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FGFR2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="apert.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="apert.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Apert Syndrome (<a href="/omim/101200,176943" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541728/table/apert.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__apert.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/101200" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">101200</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">APERT SYNDROME</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/176943" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">176943</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FIBROBLAST GROWTH FACTOR RECEPTOR 2; FGFR2</td></tr></tbody></table></div></div><div id="apert.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>FGFR2 belongs to a complex system of intracellular signaling consisting of multiple fibroblast growth factors (FGFs) and their receptors FGFRs. This signaling network functions in the control of cell proliferation, differentiation, migration, and death in many different contexts such as embryonic development, angiogenesis, immunity, and cancer. Diseases result from <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a>, <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a>, postzygotic mosaic, and/or somatic alterations in components of this network. For an excellent overview of this signaling network, along with effects of <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> and somatic alterations in FGFs and FGFRs that result in human disease, see <a class="bk_pop" href="#apert.REF.katoh.2016.1081">Katoh [2016]</a> and references therein. Additionally <a class="bk_pop" href="#apert.REF.azoury.2017.1479">Azoury et al [2017]</a> focuses on <i>FGFR</i>-related craniosynostosis.</p><p><b>Gene structure.</b> The transcript <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000141.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000141.4</a> has 18 exons, with <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1 being noncoding. The coding sequence, 648-3113 nt, encodes a signal peptide (648-710 nt) and the mature protein (711-3110 nt). This transcript may be referred to as transcript variant 1. Multiple alternatively spliced transcript variants encoding different <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> are described. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, transcripts, and protein isoforms, see <a href="/books/NBK541728/#apert.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Apert syndrome results from a gain of function of FGFR2, and as expected the range of pathogenic variants is limited. The recurrent and common variants p.Ser252Trp, p.Pro253Arg, and p.Ser252Phe cause the great majority of Apert syndrome (see <a class="figpopup" href="/books/NBK541728/table/apert.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figapertTmoleculargenetictestingusedi" rid-ob="figobapertTmoleculargenetictestingusedi">Table 1</a>, footnote 5). The corresponding nucleotide changes are in 5' end of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 7. Novel variants are also known, including a <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> variant in <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 8 [<a class="bk_pop" href="#apert.REF.torres.2015.150">Torres et al 2015</a>] and gross deletions that alter the Ig-like <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> structure (see <b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a></b>). The latter include a 1.9-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> that includes the extracellular IG-like domain IIIc (exon 8) and a 1.3-kb deletion (exon 9) that creates a chimeric IIIb/IIIc domain [<a class="bk_pop" href="#apert.REF.bochukova.2009.204">Bochukova et al 2009</a>, <a class="bk_pop" href="#apert.REF.fenwick.2011.122">Fenwick et al 2011</a>]. Three gross <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> insertions of <i>Alu</i> elements in or near exon 9, which encodes domain IIIc, are also described [<a class="bk_pop" href="#apert.REF.oldridge.1999.446">Oldridge et al 1999</a>, <a class="bk_pop" href="#apert.REF.bochukova.2009.204">Bochukova et al 2009</a>]. These novel variants are thought to result in exon skipping or other possible dysregulation that ultimately results in a gain of function.</p><p>Note that some literature describing pathogenic variants confuses the terminology of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> and <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. Alterations in exons 8 and 9, which encode IG-like domain IIIb and IIIc, respectively, may be referred to as alterations in exon IIIb and exon IIIc.</p><div id="apert.T.fgfr2_pathogenic_variants_discus" class="table"><h3><span class="label">Table 8. </span></h3><div class="caption"><p><i>FGFR2</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541728/table/apert.T.fgfr2_pathogenic_variants_discus/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__apert.T.fgfr2_pathogenic_variants_discus_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_apert.T.fgfr2_pathogenic_variants_discus_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_apert.T.fgfr2_pathogenic_variants_discus_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_apert.T.fgfr2_pathogenic_variants_discus_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_apert.T.fgfr2_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.755_756delCGinsTT</td><td headers="hd_h_apert.T.fgfr2_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser252Phe&#x000a0;<sup>1</sup></td><td headers="hd_h_apert.T.fgfr2_pathogenic_variants_discus_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000141.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000141<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_000132.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000132<wbr style="display:inline-block"></wbr>​.3</a></td></tr><tr><td headers="hd_h_apert.T.fgfr2_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.755C&#x0003e;G&#x000a0;<sup>2</sup></td><td headers="hd_h_apert.T.fgfr2_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser252Trp&#x000a0;<sup>1,&#x000a0;3</sup></td></tr><tr><td headers="hd_h_apert.T.fgfr2_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.756_758delGCCinsCTT</td><td headers="hd_h_apert.T.fgfr2_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro253Phe</td></tr><tr><td headers="hd_h_apert.T.fgfr2_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.758C&#x0003e;G&#x000a0;<sup>4</sup></td><td headers="hd_h_apert.T.fgfr2_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro253Arg&#x000a0;<sup>1,&#x000a0;3</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="apert.TF.8.1"><p class="no_margin">See <a class="figpopup" href="/books/NBK541728/table/apert.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figapertTmoleculargenetictestingusedi" rid-ob="figobapertTmoleculargenetictestingusedi">Table 1</a>, footnote 5.</p></div></dd><dt>2. </dt><dd><div id="apert.TF.8.2"><p class="no_margin">Originally published as C934G [<a class="bk_pop" href="#apert.REF.wilkie.1995.165">Wilkie et al 1995</a>]</p></div></dd><dt>3. </dt><dd><div id="apert.TF.8.3"><p class="no_margin">See <a href="#apert.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>.</p></div></dd><dt>4. </dt><dd><div id="apert.TF.8.4"><p class="no_margin">Originally published as C937G [<a class="bk_pop" href="#apert.REF.wilkie.1995.165">Wilkie et al 1995</a>]</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Transcript <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000141.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000141.4</a> encodes FGFR2 isoform 1 <a href="https://www.ncbi.nlm.nih.gov/protein/NP_000132.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000132.3</a> (also referred to as isoform BEK) of 821 amino acid residues.</p><p>A signal peptide, residues 1-21, is cleaved in post-translational processing to give the mature peptide, residues 22-821, which consists of an extracellular region composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment, and a cytoplasmic tyrosine kinase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. Residues Ser252 and Pro253, the sites of recurrent pathogenic variants, are located in the linker between the second and third immunoglobulin-like domains.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> <i>FGFR2</i> variants are thought to reduce dissociation of ligand leading to enhanced signaling.</p></div><div id="apert.Cancer_and_Benign_Tumors"><h3>Cancer and Benign Tumors</h3><p>Sporadic tumors occurring as single tumors in the absence of any other clinical findings of Apert syndrome frequently harbor somatic variants in <i>FGFR2</i> that are not present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>. In these circumstances predisposition to these tumors is not heritable.</p><p>Somatic <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a>, <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a>, and <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> fusions involving <i>FGFR2</i> are reported in diverse cancers such melanoma, breast, gastric, endometrial, lung, and cholangiocarcinoma. For an excellent overview of FGF signaling network, along with effects of <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> and somatic alterations in human disease, see <a class="bk_pop" href="#apert.REF.katoh.2016.1081">Katoh [2016]</a> and references therein.</p></div></div><div id="apert.References"><h2 id="_apert_References_">References</h2><div id="apert.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="apert.REF.agochukwu.2014.2037">Agochukwu NB, Solomon BD, Muenke M. Hearing loss in syndromic craniosynostoses: otologic manifestations and clinical findings. <span><span class="ref-journal">Int J Pediatr Otorhinolaryngol. </span>2014;<span class="ref-vol">78</span>:2037–47.</span> [<a href="/pubmed/25441602" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25441602</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.akai.2006.108">Akai T, Yamamoto K, Iizuka H, Kawakami S, Yoshida J, Kakinuma H, Yaguchi Y, Ozawa T. Syndromic craniosynostosis with elbow joint contracture. <span><span class="ref-journal">Pediatr Neurosurg. </span>2006;<span class="ref-vol">42</span>:108–12.</span> [<a href="/pubmed/16465081" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16465081</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.allanson.1986.429">Allanson JE. Germinal mosaicism in Apert syndrome. <span><span class="ref-journal">Clin Genet. </span>1986;<span class="ref-vol">29</span>:429–33.</span> [<a href="/pubmed/3742849" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3742849</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.andreou.2006.2245">Andreou A, Lamy A, Layet V, Cailliez D, Gobet F, Pfister C, Menard M, Frebourg T. Early-onset low-grade papillary carcinoma of the bladder associated with Apert syndrome and a germline FGFR2 mutation (Pro253Arg). <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:2245–7.</span> [<a href="/pubmed/16969861" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16969861</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.azoury.2017.1479">Azoury SC, Reddy S, Shukla V, Deng CS. Fibroblast growth factor receptor 2 (FGFR2) mutation related syndromic craniosynostosis. <span><span class="ref-journal">Int J Biol Sci. </span>2017;<span class="ref-vol">13</span>:1479–88.</span> [<a href="/pmc/articles/PMC5723914/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5723914</span></a>] [<a href="/pubmed/29230096" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29230096</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.bannink.2008.121">Bannink N, Joosten KF, van Veelen ML, Bartels MC, Tasker RC, van Adrichem LN, van der Meulen JJ, Vaandrager JM, de Jong TH, Mathijssen IM. Papilledema in patients with Apert, Crouzon, and Pfeiffer syndrome: prevalence, efficacy of treatment, and risk factors. <span><span class="ref-journal">J Craniofac Surg. </span>2008;<span class="ref-vol">19</span>:121–7.</span> [<a href="/pubmed/18216676" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18216676</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.barnett.2011.72">Barnett S, Moloney C, Bingham R. Perioperative complications in children with Apert syndrome: a review of 509 anesthetics. <span><span class="ref-journal">Paediatr Anaesth. </span>2011;<span class="ref-vol">21</span>:72–7.</span> [<a href="/pubmed/21073626" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21073626</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.bissacotti_steglich.2016.e596">Bissacotti Steglich EM, Steglich RB, Melo MM, de Almeida HL Jr. Extensive acne in Apert syndrome. <span><span class="ref-journal">Int J Dermatol. </span>2016;<span class="ref-vol">55</span>:e596–8.</span> [<a href="/pubmed/27428282" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27428282</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.bochukova.2009.204">Bochukova EG, Roscioli T, Hedges DJ, Taylor IB, Johnson D, David DJ, Deininger PL, Wilkie AO. Rare mutations of FGFR2 causing Apert syndrome: identification of the first partial gene deletion, and an Alu element insertion from a new subfamily. <span><span class="ref-journal">Hum Mutat. </span>2009;<span class="ref-vol">30</span>:204–11.</span> [<a href="/pubmed/18726952" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18726952</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.breik.2016.833">Breik O, Mahindu A, Moore MH, Molloy CJ, Santoreneos S, David DJ. Central nervous system and cervical spine abnormalities in Apert syndrome. <span><span class="ref-journal">Childs Nerv Syst. </span>2016;<span class="ref-vol">32</span>:833–8.</span> [<a href="/pubmed/26861132" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26861132</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.calis.2016.582">Calis M, Oznur A, Ekin O, Vargel I. Correction of brachymetatarsia and medial angulation of the great toe of Apert foot by distraction osteogenesis: a review of 7 years of experience. <span><span class="ref-journal">J Pediatr Orthop. </span>2016;<span class="ref-vol">36</span>:582–8.</span> [<a href="/pubmed/25929771" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25929771</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.choi.2008.10143">Choi SK, Yoon SR, Calabrese P, Arnheim N. A germ-line-selective advantage rather than an increased mutation rate can explain some unexpectedly common human disease mutations. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2008;<span class="ref-vol">105</span>:10143–8.</span> [<a href="/pmc/articles/PMC2474563/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2474563</span></a>] [<a href="/pubmed/18632557" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18632557</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.cinalli.1995.575">Cinalli G, Renier D, Sebag G, Sainte-Rose C, Arnaud E, Pierre-Kahn A. Chronic tonsillar herniation in Crouzon's and Apert's syndromes: the role of premature synostosis of the lambdoid suture. <span><span class="ref-journal">J Neurosurg. </span>1995;<span class="ref-vol">83</span>:575–82.</span> [<a href="/pubmed/7674004" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7674004</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.cohen.1990.36">Cohen MM, Kreiborg S. The central nervous system in the Apert syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1990;<span class="ref-vol">35</span>:36–45.</span> [<a href="/pubmed/2405668" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2405668</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.cohen.1996.45">Cohen MM Jr, Kreiborg S. A clinical study of the craniofacial features in Apert syndrome. <span><span class="ref-journal">Int J Oral Maxillofac Surg. </span>1996;<span class="ref-vol">25</span>:45–53.</span> [<a href="/pubmed/8833300" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8833300</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.cohen.1995.94">Cohen MM, Kreiborg S. Cutaneous manifestations of Apert syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1995;<span class="ref-vol">58</span>:94–6.</span> [<a href="/pubmed/7573165" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7573165</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.cohen.1992.90">Cohen MM Jr, Kreiborg S. Upper and lower airway compromise in the Apert syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1992;<span class="ref-vol">44</span>:90–3.</span> [<a href="/pubmed/1519659" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1519659</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.cohen.1993.758">Cohen MM, Kreiborg S. Visceral anomalies in the Apert syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1993;<span class="ref-vol">45</span>:758–60.</span> [<a href="/pubmed/8456856" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8456856</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.cohen.1992.655">Cohen MM Jr, Kreiborg S, Lammer EJ, Cordero JF, Mastroiacovo P, Erickson JD, Roeper P, Mart&#x000ed;nez-Fr&#x000ed;as ML. Birth prevalence study of the Apert syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1992;<span class="ref-vol">42</span>:655–9.</span> [<a href="/pubmed/1303629" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1303629</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.dalben.2006.465">Dalben GS, et al.  Oral findings in patients with Apert syndrome. <span><span class="ref-journal">J Appl Oral Sci. </span>2006;<span class="ref-vol">14</span>:465–9.</span> [<a href="/pmc/articles/PMC4327301/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4327301</span></a>] [<a href="/pubmed/19089249" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19089249</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.david.2016.1125">David DJ, Anderson P, Flapper W, Syme-Grant J, Santoreneos S, Moore M. Apert syndrome: outcomes from the Australian Craniofacial Unit's Birth to Maturity Management Protocol. <span><span class="ref-journal">J Craniofac Surg. </span>2016;<span class="ref-vol">27</span>:1125–34.</span> [<a href="/pubmed/27380568" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27380568</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.doerga.2016.191">Doerga PN, Spruijt B, Mathijssen IM, Wolvius EB, Joosten KF, van der Schroeff MP. Upper airway endoscopy to optimize obstructive sleep apnea treatment in Apert and Crouzon syndromes. <span><span class="ref-journal">J Craniomaxillofac Surg. </span>2016;<span class="ref-vol">44</span>:191–6.</span> [<a href="/pubmed/26712482" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26712482</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.elwood.2001.701">Elwood T, Sarathy PV, Geiduschek JM, Ulma GA, Karl HW. Respiratory complications during anaesthesia in Apert syndrome. <span><span class="ref-journal">Paediatr.Anaesth. </span>2001;<span class="ref-vol">11</span>:701–3.</span> [<a href="/pubmed/11696147" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11696147</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.fearon.2003.1">Fearon JA. Treatment of the hands and feet in Apert syndrome: an evolution in management. <span><span class="ref-journal">Plast Reconstr Surg. </span>2003;<span class="ref-vol">112</span>:1–12.</span> [<a href="/pubmed/12832871" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12832871</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.fenwick.2011.122">Fenwick AL, Bowdin SC, Klatt RE, Wilkie AO. A deletion of FGFR2 creating a chimeric IIIb/IIIc exon in a child with Apert syndrome. <span><span class="ref-journal">BMC Med Genet. </span>2011;<span class="ref-vol">12</span>:122.</span> [<a href="/pmc/articles/PMC3192734/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3192734</span></a>] [<a href="/pubmed/21943124" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21943124</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.fernandes.2016.1532">Fernandes MB, Maximino LP, Perosa GB, Abramides DV, Passos-Bueno MR, Yacubian-Fernandes A. Apert and Crouzon syndromes--cognitive development, brain abnormalities, and molecular aspects. <span><span class="ref-journal">Am J Med Genet A. </span>2016;<span class="ref-vol">170</span>:1532–7.</span> [<a href="/pubmed/27028366" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27028366</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.freitas.2006.142">Freitas EC, Nascimento SR, de Mello MP, Gil-da-Silva-Lopes VL. Q289P mutation in FGFR2 gene causes Saethre-Chotzen syndrome: some considerations about familial heterogeneity. <span><span class="ref-journal">Cleft Palate Craniofac J. </span>2006;<span class="ref-vol">43</span>:142–7.</span> [<a href="/pubmed/16526917" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16526917</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.glaser.2003.939">Glaser RL, Broman KW, Schulman RL, Eskenazi B, Wyrobek AJ, Jabs EW. The paternal-age effect in Apert syndrome is due, in part, to the increased frequency of mutations in sperm. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">73</span>:939–47.</span> [<a href="/pmc/articles/PMC1180614/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1180614</span></a>] [<a href="/pubmed/12900791" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12900791</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.goriely.2003.643">Goriely A, McVean GA, R&#x000f6;jmyr M, Ingemarsson B, Wilkie AO. Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">301</span>:643–6.</span> [<a href="/pubmed/12893942" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12893942</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.gorlin.1989.557">Gorlin RJ. Apert syndrome with polysyndactyly of the feet. <span><span class="ref-journal">Am J Med Genet. </span>1989;<span class="ref-vol">32</span>:557.</span> [<a href="/pubmed/2774006" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2774006</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.hibberd.2016.3215">Hibberd CE, Bowdin S, Arudchelvan Y, Forrest CR, Brakora KA, Marcucio RS, Gong SG. <em>FGFR</em>-associated craniosynostosis syndromes and gastrointestinal defects. <span><span class="ref-journal">Am J Med Genet. </span>2016;<span class="ref-vol">170</span>:3215–21.</span> [<a href="/pmc/articles/PMC5503117/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5503117</span></a>] [<a href="/pubmed/27481450" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27481450</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.hopper.2013.129">Hopper RA, Kapadia H, Morton T. Normalizing facial ratios in Apert syndrome patients with Le Fort II midface distraction and simultaneous zygomatic repositioning. <span><span class="ref-journal">Plast Reconstr Surg. </span>2013;<span class="ref-vol">132</span>:129–40.</span> [<a href="/pubmed/23508053" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23508053</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.inverso.2016.167">Inverso G, Brustowicz KA, Katz E, Padwa BL. The prevalence of obstructive sleep apnea in symptomatic patients with syndromic craniosynostosis. <span><span class="ref-journal">Int J Oral Maxillofac Surg. </span>2016;<span class="ref-vol">45</span>:167–9.</span> [<a href="/pubmed/26602951" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26602951</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.katoh.2016.1081">Katoh M. Therapeutics targeting FGF signaling network in human diseases. <span><span class="ref-journal">Trends Pharmacol Sci. </span>2016;<span class="ref-vol">37</span>:1081–96.</span> [<a href="/pubmed/27992319" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27992319</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.khong.2006a.328">Khong JJ, Anderson P, Gray TL, Hammerton M, Selva D, David D. Ophthalmic findings in Apert syndrome prior to craniofacial surgery. <span><span class="ref-journal">Am J Ophthal. </span>2006a;<span class="ref-vol">142</span>:328–30.</span> [<a href="/pubmed/16876521" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16876521</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.khong.2006b.347">Khong JJ, Anderson P, Gray TL, Hammerton M, Selva D, David D. Ophthalmic findings in Apert's syndrome after craniofacial surgery: twenty-nine years' experience. <span><span class="ref-journal">Ophthalmology. </span>2006b;<span class="ref-vol">113</span>:347–52.</span> [<a href="/pubmed/16458095" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16458095</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.kreiborg.1992.704">Kreiborg S, Barr M, Cohen MM. Cervical spine in the Apert syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1992;<span class="ref-vol">43</span>:704–8.</span> [<a href="/pubmed/1621762" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1621762</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.lajeunie.1999.443">Lajeunie E, Cameron R, El Ghouzzi V, de Parseval N, Journeau P, Gonzales M, Delezoide AL, Bonaventure J, Le Merrer M, Renier D. Clinical variability in patients with Apert's syndrome. <span><span class="ref-journal">J Neurosurg. </span>1999;<span class="ref-vol">90</span>:443–7.</span> [<a href="/pubmed/10067911" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10067911</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.lefort.1992.107">Lefort G, Sarda P, Humeau C, Rieu D. Apert syndrome with partial preaxial polydactyly. <span><span class="ref-journal">Genet Counsel. </span>1992;<span class="ref-vol">3</span>:107–9.</span> [<a href="/pubmed/1642807" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1642807</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.lloyd.2016.1510">Lloyd MS, Venugopal A, Horton J, Rodrigues D, Nishikawa H, White N, Solanki G, Noons P, Evans M, Dover S. The quality of life in adult patients with syndromic craniosynostosis from their perspective. <span><span class="ref-journal">J Craniofac Surg. </span>2016;<span class="ref-vol">27</span>:1510–4.</span> [<a href="/pubmed/27438436" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27438436</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.lohmeyer.2016.308">Lohmeyer JA, H&#x000fc;lsemann W, Mann M, Habenicht R. Transverse soft tissue distraction preceding separation of complex syndactylies. <span><span class="ref-journal">J Hand Surg Eur Vol. </span>2016;<span class="ref-vol">41</span>:308–14.</span> [<a href="/pubmed/26497594" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26497594</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.mantillacapacho.2005.403">Mantilla-Capacho JM, Arnaud L, Diaz-Rodriguez M, Barros-Nunez P. Apert syndrome with preaxial polydactyly showing the typical mutation Ser252Trp in the FGFR2 gene. <span><span class="ref-journal">Genet Couns. </span>2005;<span class="ref-vol">16</span>:403–6.</span> [<a href="/pubmed/16440883" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16440883</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.maroteaux.1987.153">Maroteaux P, Fonfria MC. Apparent Apert syndrome with polydactyly: rare pleiotropic manifestation or new syndrome? <span><span class="ref-journal">Am J Med Genet. </span>1987;<span class="ref-vol">28</span>:153–8.</span> [<a href="/pubmed/3674108" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3674108</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.mccarthy.2012.1s">McCarthy JG, Warren SM, Bernstein J, Burnett W, Cunningham ML, Edmond JC, Figueroa AA, Kapp-Simon KA, Labow BI, Peterson-Falzone SJ, Proctor MR, Rubin MS, Sze RW, Yemen TA, et al.  Parameters of care for craniosynostosis. <span><span class="ref-journal">Cleft Palate Craniofac J. </span>2012;<span class="ref-vol">49</span>:1S–24S.</span> [<a href="/pubmed/21848431" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21848431</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.mchugh.2007.596">McHugh T, Wyers M, King E. MRI characterization of the glenohumeral joint in Apert syndrome. <span><span class="ref-journal">Pediatr Radiol. </span>2007;<span class="ref-vol">37</span>:596–9.</span> [<a href="/pubmed/17453189" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17453189</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.melnik.2009.1868">Melnik BC, Schmitz G, Zouboulis CC. Anti-acne agents attenuate FGFR2 signal transduction in acne. <span><span class="ref-journal">J Invest Dermatol. </span>2009;<span class="ref-vol">129</span>:1868–77.</span> [<a href="/pubmed/19225542" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19225542</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.moloney.1996.48">Moloney DM, Slaney SF, Oldridge M, Wall SA, Sahlin P, Stenman G, Wilkie AOM. Exclusive paternal origin of new mutations in Apert syndrome. <span><span class="ref-journal">Nature Genet. </span>1996;<span class="ref-vol">13</span>:48–53.</span> [<a href="/pubmed/8673103" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8673103</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.murnaghan.2007.838">Murnaghan LM, Thurgur CH, Forster BB, Sawatzky BJ, Hawkins R, Tredwell SJ. A clinicoradiologic study of the shoulder in Apert syndrome. <span><span class="ref-journal">J Pediatr Orthop. </span>2007;<span class="ref-vol">27</span>:838–43.</span> [<a href="/pubmed/17878796" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17878796</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.nurko.2004.541">Nurko C, Quinones R. Dental and orthodontic management of patients with Apert and Crouzon syndromes. <span><span class="ref-journal">Oral Maxillofac Surg Clin North Am. </span>2004;<span class="ref-vol">16</span>:541–53.</span> [<a href="/pubmed/18088753" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18088753</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.oldridge.1997.137">Oldridge M, Lunt PW, Zackai EH, McDonald-McGinn DM, Muenke M, Moloney DM, Twigg SRF, Heath JK, Howard TD, Hoganson G, Gagnon DM, Jabs EW, Wilkie AOM. Genotype-phenotype correlation for nucleotide substitutions in the IgII-IgIII linker of FGFR2. <span><span class="ref-journal">Hum Mol Genet. </span>1997;<span class="ref-vol">6</span>:137–43.</span> [<a href="/pubmed/9002682" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9002682</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.oldridge.1999.446">Oldridge M, Zackai EH, McDonald-McGinn DM, Iseki S, Morriss-Kay GM, Twigg SR, Johnson D, Wall SA, Jiang W, Theda C, Jabs EW. WIlkie AO. De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">64</span>:446–61.</span> [<a href="/pmc/articles/PMC1377754/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377754</span></a>] [<a href="/pubmed/9973282" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9973282</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.park.1995.321">Park WJ, Theda C, Maestri NE, Meyers GA, Fryburg JS, Dufresne C, Cohen MM, Jabs EW. Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>1995;<span class="ref-vol">57</span>:321–8.</span> [<a href="/pmc/articles/PMC1801532/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1801532</span></a>] [<a href="/pubmed/7668257" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7668257</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.patton.1988.164">Patton MA, Goodship J, Hayward R, Lansdown R. Intellectual development in Apert's syndrome: a long term follow up of 29 patients. <span><span class="ref-journal">J Med Genet. </span>1988;<span class="ref-vol">25</span>:164–7.</span> [<a href="/pmc/articles/PMC1015480/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1015480</span></a>] [<a href="/pubmed/3351902" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3351902</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.pelz.1994.91">Pelz L, Unger K, Radke M. Esophageal stenosis in acrocephalosyndactyly type I. <span><span class="ref-journal">Am J Med Genet. </span>1994;<span class="ref-vol">53</span>:91.</span> [<a href="/pubmed/7802047" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7802047</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.pettitt.2017.223">Pettitt DA, Arshad Z, Mishra A, McArthur P. Apert syndrome: a consensus on the management of Apert hands. <span><span class="ref-journal">J Craniomaxillofac Surg. </span>2017;<span class="ref-vol">45</span>:223–31.</span> [<a href="/pubmed/28087285" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28087285</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.quinterorivera.2006.1337">Quintero-Rivera F, Robson CD, Reiss RE, Levine D, Benson CB, Mulliken JB, Kimonis VE. Intracranial anomalies detected by imaging studies in 30 patients with Apert syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2006;<span class="ref-vol">140</span>:1337–8.</span> [<a href="/pubmed/16691624" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16691624</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.renier.1996.66">Renier D, Arnaud E, Cinalli G, Sebag G, Zerah M, Marchac D. Prognosis for mental function in Apert's syndrome. <span><span class="ref-journal">J Neurosurg. </span>1996;<span class="ref-vol">85</span>:66–72.</span> [<a href="/pubmed/8683284" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8683284</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.schauerte.1966.67">Schauerte EW, St-Aubin PM. Progressive synosteosis in Apert's syndrome (acrocephalosyndactyly): with a description of roentgenographic changes in the feet. <span><span class="ref-journal">Am J Roentgenol Radium Ther Nucl Med. </span>1966;<span class="ref-vol">97</span>:67–73.</span> [<a href="/pubmed/5938051" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5938051</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.sidhu.1988.179">Sidhu SS, Deshmukh R. Recessive inheritance of apparent Apert syndrome with polysyndactyly? <span><span class="ref-journal">Am J Med Genet. </span>1988;<span class="ref-vol">31</span>:179–80.</span> [<a href="/pubmed/2851938" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2851938</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.slaney.1996.923">Slaney SF, Oldridge M, Hurst JA, Morriss-Kay GM, Hall CM, Poole MD, Wilkie AOM. Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>1996;<span class="ref-vol">58</span>:923–32.</span> [<a href="/pmc/articles/PMC1914616/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1914616</span></a>] [<a href="/pubmed/8651276" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8651276</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.tan.2018.205">Tan AP, Mankad K. Apert syndrome: magnetic resonance imaging (MRI) of associated intracranial anomalies. <span><span class="ref-journal">Childs Nerv Syst. </span>2018;<span class="ref-vol">34</span>:205–16.</span> [<a href="/pubmed/29198073" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29198073</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.taylor.2016.122e">Taylor JA, Bartlett SP. Discussion: first vault expansion in Apert and Crouzon-Pfeiffer syndromes: front or back? <span><span class="ref-journal">Plast Reconstr Surg. </span>2016;<span class="ref-vol">137</span>:122e–4e.</span> [<a href="/pubmed/26710042" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26710042</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.tolarova.1997.394">Tolarova MM, Harris JA, Ordway DE, Vargervik K. Birth prevalence, mutation rate, sex ratio, parents' age, and ethnicity in Apert syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1997;<span class="ref-vol">72</span>:394–8.</span> [<a href="/pubmed/9375719" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9375719</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.torres.2015.150">Torres L, Hern&#x000e1;ndez G, Barrera A, Ospina S, Prada R. Molecular analysis of exons 8, 9 and 10 of the fibroblast growth factor receptor 2 (FGFR2) gene in two families with index cases of Apert syndrome. <span><span class="ref-journal">Colomb Med (Cali). </span>2015;<span class="ref-vol">46</span>:150–3.</span> [<a href="/pmc/articles/PMC4640438/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4640438</span></a>] [<a href="/pubmed/26600631" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26600631</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.tovetj_rn.2012.572e">Tovetj&#x000e4;rn R, Tarnow P, Maltese G, Fischer S, Sahlin PE, K&#x000f6;lby L. Children with Apert syndrome as adults: a follow-up study of 28 Scandinavian patients. <span><span class="ref-journal">Plast Reconstr Surg. </span>2012;<span class="ref-vol">130</span>:572e–6e.</span> [<a href="/pubmed/23018718" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23018718</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.upton.1991.321">Upton J. Classification and pathologic anatomy of limb anomalies. <span><span class="ref-journal">Clin Plast Surg. </span>1991;<span class="ref-vol">18</span>:321–55.</span> [<a href="/pubmed/2065493" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2065493</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.von_gernet.2000.137">von Gernet S, Golla A, Ehrenfels Y, Schuffenhauer S, Fairley JD. Genotype-phenotype analysis in Apert syndrome suggests opposite effects of the two recurrent mutations on syndactyly and outcome of craniofacial surgery. <span><span class="ref-journal">Clin Genet. </span>2000;<span class="ref-vol">57</span>:137–9.</span> [<a href="/pubmed/10735635" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10735635</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.wenger.2017.62">Wenger TL, Dahl J, Bhoj EJ, Rosen A, McDonald-McGinn D, Zackai E, Jacobs I, Heike CL, Hing A, Santani A, Inglis AF, Sie KC, Cunningham M, Perkins J. Tracheal cartilaginous sleeves in children with syndromic craniosynostosis. <span><span class="ref-journal">Genet Med. </span>2017;<span class="ref-vol">19</span>:62–8.</span> [<a href="/pmc/articles/PMC5846326/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5846326</span></a>] [<a href="/pubmed/27228464" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27228464</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.wilkie.1995.165">Wilkie AO, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, Hockley AD, Hayward RD, David DJ, Pulleyn LJ, Rutland P, Malcolm S, Winter RM, Reardon W. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. <span><span class="ref-journal">Nature Genet. </span>1995;<span class="ref-vol">9</span>:165–72.</span> [<a href="/pubmed/7719344" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7719344</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="apert.REF.yoon.2009.e1000558">Yoon SR, Qin J, Glaser RL, Jabs EW, Wexler NS, Sokol R, Arnheim N, Calabrese P. The ups and downs of mutation frequencies during aging can account for the Apert syndrome paternal age effect. <span><span class="ref-journal">PLoS Genet. </span>2009;<span class="ref-vol">5</span>:e1000558</span> [<a href="/pmc/articles/PMC2700275/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2700275</span></a>] [<a href="/pubmed/19593369" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19593369</span></a>]</div></li></ul></div></div><div id="apert.Chapter_Notes"><h2 id="_apert_Chapter_Notes_">Chapter Notes</h2><div id="apert.Acknowledgments"><h3>Acknowledgments</h3><p>The authors would like to acknowledge Dr Carrie Heike for her critical review of this <i>GeneReview</i>.</p></div><div id="apert.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>30 May 2019 (ma) Review posted live</div></li><li class="half_rhythm"><div>31 December 2017 (tw) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK541728</span><span class="label">PMID: <a href="/pubmed/31145570" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">31145570</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/angelman/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/arg1/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK541728&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK541728/?report=reader">PubReader</a></li><li><a href="/books/NBK541728/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK541728" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK541728" style="display:none" title="Cite this Page"><div class="bk_tt">Wenger TL, Hing AV, Evans KN. Apert Syndrome. 2019 May 30. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK541728/pdf/Bookshelf_NBK541728.pdf">PDF version of this page</a> (563K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#apert.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#apert.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#apert.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#apert.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#apert.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#apert.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#apert.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#apert.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#apert.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#apert.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#apert.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2263[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FGFR2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4777258" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4777258" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4777258" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4777258" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301696" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> 22q11.2 Deletion Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> 22q11.2 Deletion Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">McDonald-McGinn DM, Emanuel BS, Zackai EH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301588" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Muenke Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Muenke Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kruszka P, Addissie YA, Agochukwu NB, Doherty ES, Muenke M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301368" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Saethre-Chotzen Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Saethre-Chotzen Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gallagher ER, Ratisoontorn C, Cunningham ML. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301628" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">FGFR</i>-Related Craniosynostosis Syndromes</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">FGFR</i>-Related Craniosynostosis Syndromes<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Robin NH, Falk MJ, Haldeman-Englert CR. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301398" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Simpson-Golabi-Behmel Syndrome Type 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Simpson-Golabi-Behmel Syndrome Type 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sajorda BJ, Gonzalez-Gandolfi CX, Hathaway ER, Kalish JM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=31145570" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=31145570" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e042aa6dd21425a25bce244">Apert Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Apert Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:36:06-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE881A0BE0416F510000000008E50364&amp;ncbi_session=CE881A0BE042AA51_2277SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK541728%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK541728&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK541728/&amp;ncbi_pagename=Apert Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE881A0BE042AA51_2277SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>